Page last updated: 2024-08-25

methotrexate and Colitis, Granulomatous

methotrexate has been researched along with Colitis, Granulomatous in 370 studies

Research

Studies (370)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (1.35)	18.7374
1990's	33 (8.92)	18.2507
2000's	123 (33.24)	29.6817
2010's	172 (46.49)	24.3611
2020's	37 (10.00)	2.80

Authors

Authors	Studies
Ash, R; Aslinia, FM; Sarwal, D; Yu, N	1
Classen, JM; Ebigbo, A; Fleischmann, C; Messmann, H; Muzalyova, A; Nagl, S; Römmele, C; Schnoy, E	1
Arı, D; Gökbulut, V; Kalkan, İH; Kayaçetin, E; Kılıç, ZMY; Özin, Y; Yüksel, M	1
Biemans, VBC; Bourgonje, AR; Crouwel, F; de Boer, NK; den Broeder, N; Dijkstra, G; Hoentjen, F; Maas, MHJ; Römkens, TEH; Russel, MGVM; Savelkoul, EHJ	1
Baldwin, K; Brimacombe, M; Goldfarb, A; Hopkins, D; Hyams, JS	1
Grossman, AB; Ihekweazu, FD	1
Ahuja, V; Das, P; Kante, B; Kedia, S; Kumar, P; Madhusudhan, KS; Makharia, G; Panwar, R; Ranjan, MK; Sahu, P; Sharma, R; Virmani, S; Vuyyuru, SK	1
Ahn, CS; Bowers, NL; Hrin, ML; Strowd, LC; Williams, J	1
Benkov, KJ; Colletti, RB; Crandall, W; Dotson, JL; Hunter, T; Komocsar, WJ; Liu, C; Steiner, SJ; Zhang, N	1
Berger, T; Broekaert, IJ; Foeldvari, I; Geikowski, T; Horneff, G; Hospach, A; Hufnagel, M; Klein, A; Küster, M; Minden, K; Oommen, P; Quietzsch, J; Rogalski, B; Weller-Heinemann, F; Windschall, D	1
Fredericks, E	1
Atsma, F; Bodelier, AGL; Boekema, PJ; de Boer, NK; de Jong, DJ; de Vries, AC; Gisbertz, IAM; Hoentjen, F; Jansen, FM; Jansen, JM; Jansen, SV; Kievit, W; Lutgens, MWMD; Mallant-Hent, RC; Oldenburg, B; Pauwels, RWM; Pierik, MJ; Römkens, TEH; Russel, MGVM; Smits, LJT; Tan, ACITL; Ter Borg, PCJ; van Bodegraven, AA; van der Meulen-de Jong, AE; van der Woude, CJ; van Linschoten, RCA; West, RL; Wolfhagen, FHJ	1
Choi, YM; Kim, JM; Ko, JS; Moon, JS; Yang, HR	1
Haq, SA; Momen Majumder, MS; Rasker, JJ	1
Kotsiliti, E	1
Atia, O; Daher, S; Dotan, I; Friss, C; Greenfeld, S; Kariv, R; Ledderman, N; Loewenberg Weisband, Y; Matz, E; Turner, D; Yanai, H	1
Bouma, G; Bulatović Ćalasan, M; de Boer, NKH; de Jonge, R; Fidder, HH; Koehestanie, P; Kuyvenhoven, JP; Lutgens, MWMD; Mahmmod, N; Mares, WGN; Montazeri, NSM; Nissen, LHC; Oldenburg, B; Rietdijk, ST; Struys, EA; Sundaresan, J; van Asseldonk, DP; van de Meeberg, MM	1
Anwar, I; Essam, M; Komy, ME; Mohammed, RHA; Shehab, H	1
Keller, M; Sherban, A	1
Ahuja, V; Aniwan, S; Chan, KH; Hartono, JL; Hilmi, I; Hui, AJ; Kumar, S; Lam, BCY; Leung, CM; Leung, WK; Li, MKK; Limsrivilai, J; Lo, FH; Mak, JWY; Ng, KM; Ng, SC; Ran, ZH; Sze, ASF; Tang, W; Tsang, SWC; Wei, SC; Yip, TCF	1
Bombardier, C; Deardon, R; Hazlewood, GS; Kaplan, GG; Ma, C; Marshall, DA; Panaccione, R; Pokharel, G; Seow, CH; Tomlinson, G	1
Balarezo, F; DiGiuseppe, JA; Finck, C; Hyams, JS; Isakoff, MS; Moote, D; Sayej, WN	1
Gavotto, A; Kollen, L; Werner, O	1
Chevreau, J; Foulon, A; Fumery, M; Gondry, J; Yzet, C	1
Alqarni, AM; Zeidler, MP	1
Aloi, M; Bigot, L; Croft, NM; de Ridder, L; Harris, RE; Koletzko, S; Levine, A; Neyt, M; Ruemmele, FM; Russell, RK; Turner, D; Veereman, G	1
Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, GG; Kuenzig, ME; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A; Zubieta, AA	1
Cordeiro, G; Dias, AM; Estevinho, MM; Magro, F	1
Ahuja, V; Andoh, A; Chen, M; Han, DS; Hibi, T; Hilmi, IN; Hu, PJ; Jeen, YT; Kim, HJ; Leung, WK; Matsuoka, K; Ng, SC; Ooi, CJ; Qian, J; Ran, Z; Sollano, J; Suzuki, Y; Watanabe, M; Wei, SC; Wu, K; Yang, SK	1
Bargalló, A; Domènech, E; Garcia-Planella, E; Gely, C; Gordillo, J; Llaó, J; Mañosa, M; Masnou, H; Romero, C	1
Kjeldsen, J; Knudsen, T; Larsen, MD; Lund, K; Mertz Nørgård, B; Nielsen, RG	1
Aguirre Portu, N; Aranda Alonso, Á; Calvo Galindo, R; Casas Deza, D; de Los Mozos Ruano, A; García López, S; Meriño Ibarra, EE; Solana Hidalgo, MP	1
Baert, F; Bossuyt, P; Buisson, A; D'Haens, G; Laharie, D; Lambrecht, G; Oldenburg, B; Pariente, B; Peyrin-Biroulet, L; Rivière, P; Vermeire, S	1
Decker, B; Dolezal, T; Mlcoch, T	1
Almela, P; Antolín, B; Benítez, JM; Bertoletti, F; Bujanda, L; Busquets, D; Calvet, X; Camps, B; Castaño-García, A; Castro-Poceiro, J; Domènech, E; Esteve, M; Gisbert, JP; Gomollón, F; Hernández, A; Iborra, M; López-García, A; López-Sanromán, A; Mesonero, F; Monfort I Miquel, D; Rivero, M; Rodríguez, C; Torres, P; Tosca, J; Vera, I	1
Narula, N; Tandon, P	1
Catano, J; Cohen, P; Coste, A; Dion, J; Gonin, F; La Croix, C; Le Guern, V; Legendre, P; Lorut, C; Martinod, E; Mouthon, L; Paule, R; Périé, S; Puéchal, X; Régent, A; Terrier, B; Uzunhan, Y	1
Gaidos, JKJ; Kane, SV	1
Feagan, BG; Jairath, V; Khanna, R	1
Calley, CSJ; Campbell, SC; Chiorean, MV; Fadda, HM; Fischer, M; Helper, DJ	1
Dudler, J; Fournier, N; Michetti, P; Pittet, V; Rouiller-Braunschweig, C	1
Gibson, PR; McFarlane, A; Sparrow, MP; Srinivasan, A; Van Langenberg, DR; Vasudevan, A	1
Budić, I; Djordjević, J; Djurić, Z; Pavlović, V; Šaranac, L	1
Baert, FJ; Benninga, MA; Caenepeel, P; D'Haens, GR; De Vos, M; Hoekman, DR; Hommes, DW; Stibbe, JA; Vergauwe, P; Vermeire, SA	1
Calderón, R; Delgado, E; Duca, I; Estrada, S; García Campos, F; Ramírez de la Piscina, P; Salvador, M; Sánchez, A	1
Colman, RJ; Dubinsky, MC; Lawton, RC; Rubin, DT	1
Agnholt, J; Dahlerup, J; Dige, A; Kragstrup, T; Magnusson, MK; Öhman, L; Rasmussen, TK; Uhrenholt, C	1
Ng, SC; Shi, HY	1
Church, PC; de Ridder, L; Griffiths, AM; Hyams, J; Ruemmele, F; Turner, D	1
Kollipara, R; Shimizu, I; West, CE	1
Adegbola, SO; Hart, A; Sahnan, K; Tozer, P; Warusavitarne, J	1
Hanauer, SB; Lichtenstein, GR; Sandborn, WJ	1
Doostkam, S; Fritsch, B; Guggenberger, K; Schaefer, HE; Venhoff, N; Whittaker, K	1
de Sá Freire, F; Demirci, H; Teo, HMT	1
Aviña, A; Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, G; Leung, S; Lix, L; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A	1
Qiao, YQ; Ran, ZH; Wang, TR; Zou, DW	1
Anthony, S; Gibson, PR; Raghunath, A; Scanlon, C; Sparrow, MP; van Langenberg, DR; Vasudevan, A	1
López, M; Quintas, S; Sánchez, P; Vivancos, J	1
Cohen, S; Galai, T; Moran-Lev, H; Yerushalmy-Feler, A	1
Chakravarty, SD; Farahi, K; Gasink, C; Gensler, LS; Ghosh, S; Ott, E; Ramachandran, P; Strober, BE; Yang, Z	1
Ahmad, T; Bewshea, C; Bouri, S; Chanchlani, N; Cummings, JRF; Gaya, DR; Goodhand, JR; Green, HD; Hamilton, B; Hart, AL; Heap, GA; Heerasing, NM; Hendy, P; Irving, PM; Kennedy, NA; Lees, CW; Lin, S; Lindsay, J; Mansfield, JC; McDonald, TJ; McGovern, D; Nice, R; Parkes, M; Perry, MH; Russell, RK; Sebastian, S; Selinger, CP; Thomas, A; Walker, GJ	1
Afif, W; Bernstein, CN; Bitton, A; Borgaonkar, M; Bressler, B; Chauhan, U; Halloran, B; Jones, J; Kennedy, E; Khanna, R; Leontiadis, GI; Loftus, EV; Marshall, JK; Meddings, J; Moayyedi, P; Murthy, S; Panaccione, R; Plamondon, S; Rosenfeld, G; Schwartz, D; Seow, CH; Steinhart, AH; Targownik, L; Williams, C	1
Ainsworth, MA; Nielsen, OH; Steenholdt, C	1
de Boer, NKH; Dijkstra, G; Hoentjen, F; Lissenberg-Witte, BI; Oldenburg, B; Pierik, M; Ponsioen, CY; Simsek, M; van der Meulen, AE; van der Woude, CJ; van Riswijk, MLM; Verschuren, S	1
Beasley, G; Elder, M; Rizvi, SA	1
Bezuidenhout, E; Bosch, FJ; Buchel, OC; de K Grundling, H; de Vries, CS; Fevery, J; Janse van Rensburg, J; Middlecote, BD; van Zyl, JH	1
Bjerrum, JT; Herfarth, H; Nielsen, OH; Rogler, G	1
Buisson, A; Danese, S; Fiorino, G; Peyrin-Biroulet, L	1
Guslandi, M	1
Kane, SV; Yarur, A	1
Basterra Olabarrieta, S; Bravo Rodriguez, MT; Izu Belloso, RM; Muñoz Villafranca, C	1
Atreya, R; Neumann, H; Neurath, MF	1
Kiss, LS; Lakatos, PL; Mandel, M; Miheller, P	1
De Boer, NK; Seinen, ML; van Bodegraven, AA	1
Lago, P; Magalhães, RK; Pedroto, I	1
Mudter, J; Neurath, MF	1
Arakawa, T; Fujiwara, Y; Fukushima, W; Hagihara, Y; Hirota, Y; Kamata, N; Maeda, K; Ohfuji, S; Shiba, M; Sogawa, M; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H	1
Baker, S; Baldassano, R; Cohen, S; Crandall, W; Denson, LA; Dubinsky, M; Essers, J; Evans, J; Griffiths, AM; Guthery, SL; Heyman, MB; Hyams, JS; Kellermayer, R; Kim, MO; Kim, S; Kirschner, B; Kugathasan, S; LeLeiko, N; Liu, C; Mack, D; Markowitz, J; Moulton, D; Oliva-Hemker, M; Otley, A; Patel, AS; Pfefferkorn, M; Rosh, J; Stephens, M; Walters, TD; Ziring, D	1
Katsambas, A; Koumantaki-Mathioudaki, E; Rallis, E; Stavropoulos, P; Tsiatoura, A	1
Cottone, M; Orlando, A; Renna, S	1
Falck-Ytter, YT; Gruss, CB; Heidelbaugh, JJ; Sultan, S; Terdiman, JP	1
Dassopoulos, T; Falck-Ytter, YT; Hanauer, SB; Inadomi, JM; Sultan, S	1
Anderson, F; Bernstein, CN; Bitton, A; Bourdages, R; Cohen, A; Dallaire, C; Donner, A; Enns, RA; Feagan, BG; Fedorak, RN; Greenberg, GR; Hopkins, M; Macintosh, DG; McDonald, JW; Panaccione, R; Paré, P; Ponich, TP; Saibil, F; Vandervoort, MK; Wong, CJ; Zou, G	1
Jin, J; Marginean, EC; Saloojee, N; Shukla, T	1
Cudmore, J; Seftel, M; Sisler, J; Zarychanski, R	1
Colombel, JF; Narula, N; Peyrin-Biroulet, L	1
Desalermos, AP; Farraye, FA; Frank, S	1
Dubinsky, MC; Rabizadeh, S; Vahabnezhad, E	1
Dassopoulos, T; Gutierrez, A	1
Chao, K; Chen, B; Chen, M; Chen, Y; He, Y; Mao, R; Tang, R; Xu, P; Zeng, Z; Zhu, Z	1
Arora, H; Debelenko, LV; Guglani, L; Madani, S; McGrath, EJ; Mutyala, R	1
Amiot, A; Bastuji-Garin, S; Belhassan, M; Chauvin, A; Delchier, JC; Le Baleur, Y; Le Thuaut, A; Mesli, F	1
Amil Dias, J; Barabino, A; Braegger, CP; Bronsky, J; Buderus, S; De Ridder, L; Dignass, A; Eliakim, A; Escher, JC; Fagerberg, UL; Griffiths, A; Hugot, JP; Kierkus, J; Kolacek, S; Koletzko, S; Kolho, KL; Levine, A; Lionetti, P; Martín-de-Carpi, J; Miele, E; Navas López, VM; Paerregaard, A; Ruemmele, FM; Russell, RK; Serban, DE; Shaoul, R; Turner, D; Van Rheenen, P; Veereman, G; Veres, G; Weiss, B; Wilson, D; Winter, H	1
Irving, PM	1
Antunes, O; Filippi, J; Hébuterne, X; Peyrin-Biroulet, L	1
Dieleman, LA; Fedorak, DK; Fedorak, RN; Halloran, BP; Huang, V; Kroeker, KI; Ma, C	1
Cabrera, J; Carvalho, R; Griffiths, AM; Grossman, AB; Hitch, MC; Hyams, JS; Kappelman, M; Keljo, DJ; Leleiko, NS; Lerer, T; Mack, DR; Markowitz, J; Oliva-Hemker, M; Otley, AR; Pfefferkorn, MD; Rick, J; Rosh, JR; Saeed, SA; Sunseri, W	1
Andrews, J; Barr, G; Chapman, G; Colliwshaw, J; Huang, T; Jones, DB; Kariyawasam, VC; Katelaris, PH; Leong, RW; Lunney, PC; McDonald, C; Middleton, K; Selinger, CP; Wang, RR	1
Feagan, BG; MacDonald, JK; McDonald, JW; Tsoulis, DJ; Wang, Y	1
Chande, N; MacDonald, JK; McDonald, JW; Patel, V; Wang, Y	1
Baldassano, RN; Bousvaros, A; Cohen, A; Deslandres, C; Doveh, E; Griffiths, AM; Grossman, AB; Lerner, A; Levine, A; Lu, Y; Noble, A; Rosh, JR; Turner, D; Wilson, DC; Wilson, ML	1
Charro, M; Domènech, E; García-López, S; Gisbert, JP; Gomollón, F; Muñoz, F; Rubio, S	1
Alves, VB; Basso, PJ; Bonfá, G; Cardoso, CR; Fonseca, MT; Nardini, V; Sales-Campos, H	1
Czaja-Bulsa, G; Czkwianianc, E; Dadalski, M; Grzybowska-Chlebowczyk, U; Iwańczak, B; Kierkuś, J; Korczowski, B; Krzesiek, E; Maślana, J; Mierzwa, G; Szymańska, E; Sładek, M; Toporowska-Kowalska, E; Wegner, A; Więcek, S; Żabka, A; Łazowska, I	1
Garg, R; Gerber, ME; Rusciolelli, C	1
Laharie, D; Poullenot, F	1
Damen, G; de Meij, T; de Ridder, L; Escher, JC; George, E; Haisma, SM; Hendriks, D; Hummel, T; Kindermann, A; Lijftogt, T; Mearin, ML; Norbruis, O; van Rheenen, P	1
Bailey, C; Fuller, LC; Laftah, Z; Lewis, F; Setterfield, J; Zaheri, S	1
Borovaya, A; Hartlieb, E; Horváth, ON; Klose, J; Roider, E; Ruzicka, T; Sárdy, M; Waschke, J	1
Ben-Horin, S; Bossuyt, P; Bouguen, G; Dotan, I; Jussila, A; Karmiris, K; Katsanos, KH; Kruis, W; Legido, J; Li, AC; Moreels, T; Naismith, GD; Preiss, JC; Scarcelli, A; Sorrentino, D; Steinwurz, F; Subramaniam, K; Tarabar, D; Yanai, H; Zaganas, IV	1
Chong, K; Melmed, GY; Shah, ED; Siegel, CA	1
Karatzas, P; Mantzaris, GJ; Papamichael, K	1
Hojsak, I; Jadrešin, O; Kolaček, S; Mišak, Z; Močić Pavić, A	1
Büning, J; Fellermann, K; Lehnert, H; Mackenroth, T; Möller, S; Olsen, V; Schmidt, KJ; Schröder, T; Sina, C	1
Bitton, A; Bressler, B; D'Haens, G; Donner, A; Feagan, BG; Greenberg, GR; Khanna, R; Levesque, BG; MacIntosh, D; Morris, JC; Panaccione, R; Paré, P; Sandborn, WJ; Stitt, LW; Vandervoort, MK; Vermeire, S; Zou, G	1
Bruining, DH; Deepak, P	1
Bajaj, V; Ralph, S; Sripathy, TK	1
Choi, JR; Kim, JH; Park, HJ; Park, JJ; Park, YM; Youn, YH; Yun, GW	1
Scherkenbach, LA; Stumpf, JL	1
Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S	1
Chande, N; Feagan, BG; Marshall, JK; Nelson, S; Parker, CE; Sandborn, WJ; Seow, CH	1
Hanauer, S; Raj, R; Trivedi, I	1
Adhami, K; Camp, B; Jacob, V; Kiuru, M; Magro, C; Wildman, H	1
Antunes, O; Filipe, V; Filippi, J; Hébuterne, X; Louis, E; Peyrin-Biroulet, L; Reenaers, C; Roblin, X; Salleron, J	1
Ben-Horin, S; Bojic, D; Christodoulou, DK; Fiorino, G; Hernandez, V; Jojic, N; Kaimakliotis, I; Karmiris, K; Katsanos, KH; Kopylov, U; Koutroubakis, IE; Mantzaris, GJ; Odes, S; Papageorgiou, N; Papamichael, K; Paspatis, G; Pineda, JR; Sanroman, L; Strongili, K; Tsianos, EV; van der Woude, CJ	1
Allen, PB; Peyrin-Biroulet, L	1
Herfarth, HH	1
Begun, J	1
Afzali, A; Hu, JK; Lee, SD; Park, CJ; Sharma, P; Sinanan, MN; Zhu, K	1
Beutler, BD; Cohen, PR	1
Abitbol, V; Chaussade, S; Lahmek, P; Lesgourgues, B; Nahon, S; Paupard, T; Peyrin-Biroulet, L	1
Cook, GK; Fadda, HM; Fischer, M; Jones, DR; Siva, S	1
Bello-Peón, MJ; Fernández-Fernández, FJ; Pérez-Valcárcel, J	1
Grossman, AB; Maxwell, EC	1
Grossi, V; Hyams, JS	1
Annese, V; Deiana, S; Gabbani, T; Lunardi, S; Manetti, N	1
Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G	1
Hagiwara, SI; Kagimoto, S; Kubota, M; Nambu, R	1
Aalykke, C; Ekenberg, C; Friis-Møller, N; Ulstrup, T	1
Achkar, JP; Brzezinski, A; Garber, A; Horton, N; Lashner, BA; Philpott, J; Shen, B; Wu, X	1
Colombel, JF; Lewis, JD; Osterman, MT; Peyrin-Biroulet, L; Robinson, AM; Sandborn, WJ; Zhou, Q	1
Bar-Gil Shitrit, A; Ben-Horin, S; Chowers, Y; Eliakim, R; Engel, T; Fudim, E; Kopylov, U; Lang, A; Paul, S; Picard, O; Roblin, X; Ungar, B; Williet, N; Yavzori, M	1
Hameeteman, WH; Jeuring, SF; Jonkers, DM; Liu, LY; Masclee, AA; Oostenbrug, LE; Pierik, MJ; Romberg-Camps, MJ; van den Heuvel, TR; Zeegers, MP	1
Aicart, M; Alcaín, G; Almela, P; Arguelles-Arias, F; Arias-Rivera, ML; Barreiro-de Acosta, M; Barrio, J; Beltrán, B; Benítez, JM; Bermejo, F; Botella, B; Bujanda, L; Busquets, D; Calvet, X; Casanova, MJ; Castaño-Milla, C; Castro, E; Castro, L; Ceballos, D; Chaparro, M; Cortés, X; Domènech, E; Domínguez, M; Domínguez-Antonaya, M; Dueñas, C; Esteve, M; Fernández-Salazar, L; García-Herola, A; García-López, S; García-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Garrido, E; Gisbert, JP; Gómez-García, M; Gomollón, F; González-Lama, Y; Guardiola, J; Gutiérrez, A; Hernández-Martínez, A; Hervías, D; Hinojosa, J; Huguet, JM; Jauregui-Amezaga, A; Khorrami, S; Leo, E; Llaó, J; Lorente-Poyatos, R; Mañosa, M; Marín-Jiménez, I; Marrero, JM; Martín-Arranz, M; Martinez-Montiel, MP; Menacho, M; Merino, O; Monfort, D; Moraleja, I; Muñoz, C; Muñoz, F; Nantes, O; Navarro-Llavat, M; Novella, MT; Opio, V; Pajares, R; Pérez-Calle, JL; Pérez-Martínez, I; Pineda, JR; Ponferrada, A; Ramírez-de la Piscina, P; Ramos, L; Robles-Alonso, V; Rodríguez, C; Rodríguez, GE; Rodríguez-Pérez, A; Rojas-Feria, M; Roncedo, O; Sánchez-Torres, A; Sicilia, B; Taxonera, C; Tosca, J; Van Domselaar, M; Vázquez, JM; Vega-López, AB	1
Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W	1
Durant, N; Hyndman, L; Jester, T; Lowe, R; Reese, JM; Savage, RJ; Wallace, S; Wang, T	1
Burgis, J; Christofferson, M; Nakayuenyongsuk, W; Nguyen, K; Park, KT	1
Chao, K; Gao, X; Hu, P; Huang, Z; Li, M; Tang, J; Zhi, M	1
Im, JP; Kim, JW; Lee, H; Lee, KM; Park, DI; Park, JJ; Yang, SK; Ye, BD; Yoon, H; Yoon, SN	1
Agnholt, J	1
Bertomoro, P; D'Incà, R; Lamboglia, F; Oliva, L; Sturniolo, GC	1
Forbes, A	1
Burakoff, R	1
Atwal, P; Barclay, AR; Garrick, V; McGrogan, P; Russell, RK	1
Grimaldi, C	1
Koning, E; Lerebours, E; Michot, F; Savoye, G; Savoye-Collet, C; Tougeron, D	1
Justum, AM; Muller, CD; Ratajczyk, J; Reimund, JM; Sola, B	1
Carbonnel, F	1
Amann, K; Boxberger, F; Goertz, RS; Hahn, EG; Janka, R; Konturek, PC; Maennlein, G; Naegel, A; Wein, A	1
Rogler, G; Vavricka, SR	1
Burger, DC; Florin, TH	1
Hou, JK; Mahadevan, U	1
Broide, E; Bujanover, Y; Fradkin, A; Lerner, A; Levine, A; Shapiro, R; Weiss, B	1
Ahishali, E; Akyuz, F; Badur, S; Demir, K; Gurel Polat, N; Ibrisim, D; Kaymakoglu, S; Mungan, Z; Poturoglu, S	1
Arrighi, HM; Hass, S; Marehbian, J; Sandborn, WJ; Tian, H	1
Boix, J; Cabré, E; Domènech, E; Leal, C; Lorenzo-Zuñiga, V; Mañosa, M; Moreno, V; Naves, JE	1
Ruemmele, FM	1
Bar-Meir, S	1
Chande, N; Macdonald, JK; McDonald, JW; Patel, V	1
Berard, F; Graber, I; Kanitakis, J; Nicolas, JF; Said, BB; Saurin, JC	1
Hausmann, J; Herrmann, E; Schröder, O; Zabel, K	1
Belaiche, J; Louis, E; Reenaers, C	1
Lakatos, PL	1
Reichel, C; Streit, J; Wunsch, S	1
Chau, TN; Cheung, WI; Lai, KB; Lee, CK; Leung, VK; Lin, CK; Lo, FH	1
English, JC; Hawryluk, EB; Izikson, L	1
Angelucci, E; Cesarini, M; Vernia, P	1
Cabré, E; Domènech, E; Leal-Valdivieso, C; Mañosa, M; Naves, JE; Zabana, Y	1
Bischoff, A	1
Creed, TJ; Dixit, A; Fraser, A; Parker, R; Probert, CS	1
Calderón, R; Delgado, E; Enciso, C; Estrada, S; García-Campos, F; Ramírez de la Piscina, P; Salvador, M; Zabaleta, S	1
Beaugerie, L; Carrat, F; Cosnes, J; Nion-Larmurier, I; Seksik, P; Sokol, H; Vienne, A	1
Bouchard, D; Capdepont, M; Castinel, A; Gaye, D; Juguet, F; Laharie, D; Pigot, F; Roumeguère, P; Zerbib, F	1
Bressler, B; Rossman, D; Wong, JC	1
Boyle, B; Crandall, W; Kumar, S; Mackner, L; Moses, J; Ross, C	1
Kane, S	1
Revington, PJ; Williams, JV	1
Colombel, JF; D'Hoore, A; Danese, S; Dignass, A; Gassull, M; Gomollón, F; Hommes, DW; Lémann, M; Lindsay, JO; Michetti, P; O'Morain, C; Oresland, T; Söderholm, J; Stange, EF; Travis, SP; Van Assche, G; Windsor, A	1
Aratari, A; Margagnoni, G; Papi, C; Papi, V; Triolo, L	1
Karaca, C	1
Ahmed, SF; Bishop, J; Hassan, K; Malik, S; McGrogan, P; Russell, RK; Wong, SC	1
Capiak, KM; Lebwohl, B; Present, DH; Swaminath, A	1
Mo, N; Muthu, S; O'Sullivan, M	1
Abdelgadir, I; Chande, N; Gregor, J	1
Belleannée, G; Capdepont, M; Chabrun, E; de Lédinghen, V; Laharie, D; Razaire, S; Reffet, A; Subtil, C	1
Deslandres, C; Noble, A; Willot, S	1
Baidoo, L; Barrie, AM; Binion, DG; El Mourabet, M; Hashash, JG; Issa, M; Katz, JA; Levesque, MC; Regueiro, M; Schwartz, MB; Sun, NH; Swoger, JM	1
Dubinsky, MC; Ford, AC; Khan, KJ; Moayyedi, P; Talley, NJ; Ullman, TA	1
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C	1
Barkey, J; Benchimol, EI; Boland, M; Kempinska, A; Mack, A; Mack, DR	1
Castro Laria, L; Castro Márquez, C; Caunedo Álvarez, A; Cordero Ruiz, P; Herrerías Gutiérrez, JM; Méndez Rufián, V; Romero Vázquez, J	1
Blonski, W; Buchner, AM; Lichtenstein, GR	1
Absah, I; Faubion, WA	1
Half, E; Konikoff, FM; Lev, LB; Naftali, T; Yablecovitch, D; Yablekovitz, D	1
Cottone, M; Mocciaro, F; Orlando, A; Renna, S	1
Chu, DH; Rosenbach, M; Van Voorhees, AS	1
Bell, SJ; Brown, SJ; Chan, FK; Chan, H; Chow, DK; Connell, WR; De Cruz, P; Desmond, PV; Kamm, MA; Leong, RW; Lust, M; Ng, SC; Prideaux, L; Sung, JJ; Williams, J; Wu, JC	1
Clark, T; Ford, AC; Greer, DP; Hamlin, PJ; Suares, NC; Warren, L	1
Algaba, A; Barbero-Villares, A; Bermejo, F; Gisbert, JP; López-Sanromán, A; Maté, J; Mendoza Jiménez-Ridruejo, J; Mendoza, JL; Moreno-Otero, R; Pajares, R; Pérez-Calle, JL; Taxonera, C	1
Balogh, M; David, G; Erdelyi, Z; Golovics, PA; Horvath, A; Kiss, LS; Komaromi, E; Lakatos, L; Lakatos, PL; Lovasz, BD; Mester, G; Molnar, C; Pandur, T; Szathmari, M; Szipocs, I; Veres, G	1
Kiss, SL; Lakatos, PL; Lorinczy, K; Miheller, P	1
Ford, AC; Greer, D; Hamlin, J; Sprakes, MB; Warren, L	1
Bigard, MA; Billioud, V; Bronowicki, JP; Chevaux, JB; Gibot, S; Guéant, JL; Massin, F; Oussalah, A; Peyrin-Biroulet, L; Williet, N	1
Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD	1
Gisbert, JP; Gomollón, F; Hinojosa, J; López San Román, A	1
Ahmed, SF; Akobeng, AK; Bourke, B; Fagbemi, A; Loganathan, S; Malik, S; Naik, S; Russell, RK; Shah, N; Thomas, A; Wilson, DC; Wilson, ML	1
Limdi, JK; Muhammad, R; Wong, CL	1
Ahmed, SF; Bakhshi, A; Bishop, J; Garrick, V; Malik, S; Mason, A; McGrogan, P; Russell, RK; Young, D	1
Katsanos, KH; Tsianos, EV; Tsianos, VE	1
Barclay, ML; Roberts, RL	1
Boyle, B; Colletti, RB; Crandall, WV; Kappelman, MD; King, E; Lee, GJ; Pratt, JM	1
Makol, A; Sokumbi, O; Warrington, KJ; Wetter, DA	1
Bukiia, AS; Karoli, NA; Rebrov, AP; Roshchina, AA; Steshenko, RN	1
Ammendola, A; Diculescu, M; Dietrich, B; Fellermann, K; Hartmann, H; Hentsch, B; Herrlinger, KR; Howaldt, S; Nikolov, R; Otte, JM; Petrov, A; Reindl, W; Stange, EF; Stoynov, S; Strauch, U; Sturm, A; Voiosu, R	1
Caccaro, R; D'Incà, R	1
Asher, L; Chande, N; Choi, Y; Gregor, JC; Kim, RB; Patel, V; Ponich, T; Tirona, R; Urquhart, B; Wilson, A	1
Fragny, D; Jachiet, M; Lepajolec, C; Lependu, C; Mariette, X; Seror, R	1
Feagan, BG; Macdonald, JK; McDonald, JW; Tsoulis, DJ	1
Herfarth, HH; Isaacs, KL; Long, MD	1
Bouma, G; de Boer, NK; Mulder, CJ; Oldenburg, B; Ponsioen, CY; Seinen, ML; van Bodegraven, AA	1
Niemelä, S	1
D'Haens, G; Daperno, M	1
Alstead, EM; Nelson-Piercy, C	1
Alfadhli, AA; Feagan, BG; McDonald, JW	2
Fleig, WE	1
Hoffmann, J; Zeitz, M	1
Encke, J; Erb, G; Flosdorff, P; Ganten, M; Grüber-Hoffmann, B; Hansmann, J	1
Göke, B; Ochsenkühn, T; Sackmann, M	1
Fraser, AG	1
Sugita, T	1
Schröder, O; Stein, J	2
Beglinger, Ch	1
Becker, MA; Ene-Stroescu, D; Hanauer, SB; Klapman, JB	1
Hommes, D	1
Konrad, A; Seibold, F	1
Almog, S; Bar-Meir, S; Chowers, Y; Fishbein, E; Halkin, H; Kurnik, D; Loebstein, R	1
Amouretti, M; Bens, G; Beylot, C; Beylot-Barry, M; Laharie, D; Noblesse, I; Vergier, B	1
Batres, LA; Gabriel, CA; Tsou, VM	1
Korelitz, BI	2
Ardizzone, S; Bianchi Porro, G; Bollani, S; Colombo, E; Imbesi, V; Manzionna, G	1
Blumenstein, I; Schröder, O; Schulte-Bockholt, A; Stein, J	1
Barrett, T; Buchman, AL; Halverson, A; Kastin, DA; Wallin, A	1
Bebb, JR; Scott, BB	1
Beau, P; Blanchet, E; Frat, JP	1
Ansari, A; Hirst, J; Raoof, S; Sanderson, JD; Soon, SY; Yaneza, M	1
Kamm, MA	1
Naumann, M; Schröder, O; Stein, J	1
Adams, AE; Curiel, C; Drews, R; Falchuk, KR; Kadin, ME; Kupper, TS; Zwicker, J	1
Dejaco, C; Knoflach, P; Petritsch, W; Reinisch, W; Tilg, H; Vogelsang, H	1
Alves, A; Bouhnik, Y; Joly, F; Lavergne-Slove, A; Panis, Y; Pocard, M; Valleur, P	1
Stiefelhagen, P	1
Herrlinger, K; Stange, EF	1
Baker, DE	1
Afchain, P; Beaugerie, L; Cosnes, J; Gendre, JP; Nion-Larmurier, I; Tiret, E	1
Beaugerie, L; Bouhnik, Y; Cosnes, J; Etienney, I; Gendre, JP; Lémann, M; Matuchansky, C; Modigliani, R; Rambaud, JC	1
Hyams, JS; Markowitz, JF	1
Harris, AW; Hayee, BH	1
Barthel, HR; Gille, T; Halbsguth, A; Kramer, M	1
Dienes, HP; Kruis, W; Lanyi, B	1
Ahmad, T; Barnardo, MC; Cummings, JR; Herrlinger, KR; Jewell, DP; Schwab, M	1
Das, KM; Sun, JH	1
Chande, N; Gregor, J; Ponich, T	1
Kruis, W	1
Panaccione, R	1
Blumenstein, I; Schröder, O; Stein, J	1
Baldassano, RN; Jacobstein, DA; Leonard, M; Mamula, P; Markowitz, JE	1
Bouhnik, Y; Chowers, Y; Colombel, JF; Cortot, A; D'Haens, G; Forbes, A; Gionchetti, P; Kitis, G; Kroesen, J; Lémann, M; Marteau, P; Mortensen, NJ; Oresland, T; Prantera, C; Stange, EF; Starlinger, M; Tiret, E; Travis, SP	1
Barta, Z; Tóth, L; Zeher, M	1
Binion, DG; Galbraith, SS; Rogers, RS; Tonkovic-Capin, V; Yancey, KB	1
Hudson, N; Lewis, FM; Preston, PW	1
Adhoute, X; Amouretti, M; Bertet, J; Boué-Lahorgue, X; Castéra, L; Couzigou, P; de Lédinghen, V; Foucher, J; Laharie, D; Rullier, A; Zerbib, F	1
De Pedro-Esteban, A; González-Carro, P; Legaz-Huidobro, ML; Pérez-Roldán, F; Roncero García-Escribano, O; Ruiz-Carrillo, F; Soto-Fernández, S; Valbuena-González, M	1
Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R	1
Moser, C; Schmidt, C; Stallmach, A; Wittig, BM; Zeitz, M	1
Büning, C; Lochs, H	1
Clark, CA; Mehta, BH; Pruchnicki, MC; Rodis, JL	1
Belbouab, R; Cézard, JP; Goulet, O; Narebski, K; Ruemmele, FM; Schmitz, J; Turck, D; Uhlen, S	1
Griggs, LR; Schwartz, DA	1
Baert, F; D'Haens, G; Noman, M; Rutgeerts, P; Van Assche, G; Vermeire, S	1
Bang, SM; Chung, JH; Hwang, JH; Kang, HY; Kim, H; Lee, JS; Park, YS	1
Garrido Gómez, E; López San Román, A; Milicua Salamero, JM; Rivero Fernández, M; Rodríguez Gandía, MA; Ruiz Del Arbol Olmos, L	1
Hinsberger, A; Ravikumara, M; Spray, CH	1
Gibson, PR; Iser, JH; Nathan, DM	1
Lakatos, L; Lakatos, PL	1
Brechmann, T; Heyer, C; Schmiegel, W	1
Angelucci, E; Baert, F; Caprilli, R	1
Bude, S; Shandwick, W	1
Avellini, C; Maiero, S; Sorrentino, D; Terrosu, G	1
Akobeng, AK	1
Baldassano, R; Gilman, AR; Griffiths, AM; Grossman, AB; Kugathasan, S; Rosh, J; Turner, D	1
Aitken, S; Arnott, ID; Dahele, A; Din, S; Fennel, J; Satsangi, J; Shand, AG	1
Cabré, E; Domènech, E; Garcia-Planella, E; Gassull, MA; Mañosa, M; Masnou, H; Navarro, M; Zabana, Y	1
Baert, F; Caenepeel, P; Coche, JR; D'Haens, G; De Vos, M; Donner, A; Feagan, BG; Hommes, D; Lambrecht, GL; Mana, F; Ochsenkühn, T; Rutgeerts, P; Stitt, L; Tuynman, H; van Assche, G; van Bodegraven, AA; Van De Mierop, FJ; van der Woude, J; van Deventer, S; Van Hootegem, PP; Vergauwe, P; Vermeire, S	1
Ahmed, SF; Hassan, K; McGrogan, P; Weaver, LT; Wong, SC	1
Beau, P; Charpignon, C	1
Baert, F; D'Haens, G; Magdelaine-Beuzelin, C; Noman, M; Paintaud, G; Rutgeerts, P; Ternant, D; Van Assche, G; Vermeire, S; Watier, H	1
Korelitz, BI; Present, DH	1
Feagan, BG; Fedorak, RN; Gillies, R; Greenberg, GR; Hopkins, M; Irvine, EJ; Rochon, J; Steinhart, AH; Sutherland, L; Wild, G	1
Weinblatt, ME	1
Driessen, WM; Houben, MH; van Spreeuwel, JP; van Wijk, HJ	1
Stark, ME; Tremaine, WJ	1
van Hogezand, RA	1
George, J; Kornbluth, A; Sachar, DB	1
Abreu García, L; Blasco Colmenarejo, MM; de la Morena Madrigal, EJ	1
Baron, TH; Elson, CO; Truss, CD	1
Daum, F; Grancher, K; Mandel, F; Markowitz, J	1
Kozarek, RA	3
Rochon, J	1
Pansard, E; Pierrugues, R	1
Chamiot-Prieur, C; Colombel, JF; Gendre, JP; Halphen, M; Lémann, M; Mesnard, B; Messing, B; Modigliani, R; Rambaud, JC	1
Lichtenstein, GR; Stotland, BR	1
Arber, N; Becker, S; Broide, E; Eliakim, R; Fich, A; Gilat, T; Keter, D; Lavy, A; Moshkowitz, M; Odes, S; Oren, R; Patz, J; Pomeranz, I; Reisfeld, I; Shirin, C; Shirin, H; Villa, Y	1
Baert, F; Rutgeerts, P	2
Kaufman, SS; Mack, DR; Ramey, L; Vanderhoof, JA; Young, R	1
Tytgat, GN; van Deventer, SJ	1
Feagan, BG	1
Adal, K; Dumot, JA; Lashner, BA; Petras, RE	1
Baert, F; D'Haens, G; Rutgeerts, P; Vandeputte, L	1
Hanauer, SB; Stein, RB	1
Kougo, Y	1
Bellaïche, G; Ley, G; Maisonneuve, L; Nouts, A; Slama, JL	1
Egan, LJ; Leighton, JA; Lipsky, JJ; Mays, DC; Pike, MG; Sandborn, WJ; Tremaine, WJ; Zinsmeister, AR	1
Feagan, BG; Fedorak, RN; Greenberg, GR; Hanauer, SB; Hopkins, M; Irvine, EJ; Koval, J; McDonald, JW; Steinhart, AH; Sutherland, L; Wild, G; Wong, CJ	1
Sartor, RB	1
Bouhnik, Y; Colombel, JF; Cortot, A; Cosnes, J; Lémann, M; Mesnard, B; Modigliani, R; Rambaud, JC; Zenjari, T	1
Faubion, WA; Sandborn, WJ	1
Roseau, E	1
Baker, AL; Conjeevaram, HS; Hanauer, SB; Kuan, SF; Schiano, TD; Te, HS	1
Chong, RY; Cohen, RD; Hanauer, SB	1
Egan, LJ; Lipsky, JJ; Mays, DC; Sandborn, WJ; Tremaine, WJ	1
Bemelman, WA; Griffioen, G; Hermans, J; Ivenski, M; van Hogezand, RA; Veenendaal, RA	1
Martreau, P	1
Lichtenstein, GR; Yang, YX	1
Dignass, A; Roznowski, AB	1
Rampton, DS	1
Rutgeerts, PJ	1
Lichtenstein, GR	1
Hawthorne, AB	1
Fishman, M	1
Baldassano, R; Batres, LA; Ng, D; Stephens, M	1
Paré, P	1
Colombel, JF; Cortot, A; Cosnes, J; Dewit, O; Hafraoui, S; Lémann, M; Marteau, P; Modigliani, R	1
DiPiro, JT; Vandell, AG	1
Belaiche, J; Delwaide, J; Gast, P; Louis, E	2
Chiche, A; Colombel, JF; Cortot, A; Gower-Rousseau, C; Mesnard, B; Paris, JC	1
Ball, TJ; Botoman, VA; Gelfand, MD; Kozarek, RA; Patterson, DJ; Wilske, KR	1
Moeschlin, S	1
Schwartz, RS; Skinner, MD	1
Fogel, M; Lewis, M; Segel, D; Shadduck, RK; Stolzer, BL; Winkelstein, A	1

Reviews

96 review(s) available for methotrexate and Colitis, Granulomatous

Article	Year
[IBD and pregnancy: From conception to birth]. Gynecologie, obstetrique, fertilite & senologie, 2020, Volume: 48, Issue:6 Topics: Cesarean Section; Colitis, Ulcerative; Crohn Disease; Delivery, Obstetric; Female; Fertilization; Fetus; Gestational Age; Humans; Infant, Newborn; Infertility; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thalidomide	2020
How does methotrexate work? Biochemical Society transactions, 2020, 04-29, Volume: 48, Issue:2 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cell Line; Crohn Disease; Folic Acid; Humans; Inflammation; Janus Kinases; MAP Kinase Signaling System; Methotrexate; Psoriasis; Signal Transduction; STAT Transcription Factors	2020
Inflammatory Bowel Disease - Non-biological treatment. Pharmacological research, 2020, Volume: 160 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Digestive System Surgical Procedures; Gastrointestinal Agents; Humans; Mesalamine; Methotrexate; Tacrolimus; Treatment Outcome	2020
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia. Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:3 Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Asia; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Female; Gastroenterology; Humans; Immunosuppressive Agents; Male; Methotrexate; Monitoring, Physiologic; Pacific Islands; Practice Guidelines as Topic; Pregnancy; Remission Induction; Societies, Medical; Tuberculosis, Gastrointestinal	2021
Methotrexate pneumonitis in a patient with Crohn's disease, during the COVID pandemic: An unusual clinical case and review of the literature. Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; COVID-19; Crohn Disease; Female; Humans; Methotrexate; Middle Aged; Pneumonia	2021
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn's Disease. Applied health economics and health policy, 2021, Volume: 19, Issue:4 Topics: Cost-Benefit Analysis; Crohn Disease; Humans; Methotrexate; Quality-Adjusted Life Years	2021
Sexuality, Fertility, and Pregnancy in Crohn's Disease. Gastroenterology clinics of North America, 2017, Volume: 46, Issue:3 Topics: Congenital Abnormalities; Crohn Disease; Female; Fertility; Humans; Immunosuppressive Agents; Infant, Low Birth Weight; Infant, Small for Gestational Age; Infertility, Female; Infertility, Male; Male; Methotrexate; Pregnancy; Pregnancy Complications; Premature Birth; Risk Factors; Sexual Health; Stillbirth; Tumor Necrosis Factor-alpha	2017
The Evolution of Treatment Paradigms in Crohn's Disease: Beyond Better Drugs. Gastroenterology clinics of North America, 2017, Volume: 46, Issue:3 Topics: Adrenal Cortex Hormones; Algorithms; Azathioprine; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Prognosis; Tumor Necrosis Factor-alpha	2017
Therapeutic role of methotrexate in pediatric Crohn's disease. Bosnian journal of basic medical sciences, 2018, Aug-01, Volume: 18, Issue:3 Topics: Adolescent; Azathioprine; Child; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Patient Safety; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha	2018
Methotrexate Pneumonitis in Crohn's Disease: A Rare Case Report and Review of Literature. Archivos de bronconeumologia, 2018, Volume: 54, Issue:10 Topics: Aged; Crohn Disease; Female; Humans; Immunosuppressive Agents; Methotrexate; Pneumonia	2018
Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis. Inflammatory bowel diseases, 2018, 09-15, Volume: 24, Issue:10 Topics: Antimetabolites, Antineoplastic; Child; Crohn Disease; Humans; Methotrexate; Treatment Outcome	2018
The state of the art on treatment of Crohn's disease. Journal of gastroenterology, 2018, Volume: 53, Issue:9 Topics: Adrenal Cortex Hormones; Asia; Azathioprine; Crohn Disease; Drug Monitoring; Humans; Immunomodulation; Immunosuppressive Agents; Incidence; Infliximab; Methotrexate; Purines; Remission Induction; Thalidomide; Thionucleosides; Treatment Outcome; Tumor Necrosis Factor-alpha	2018
Anti-TNF Therapy in Crohn's Disease. International journal of molecular sciences, 2018, Jul-31, Volume: 19, Issue:8 Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Crohn Disease; Gastrointestinal Agents; Humans; Immunologic Factors; Methotrexate	2018
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary. Gastroenterology, 2019, Volume: 156, Issue:1 Topics: Anti-Inflammatory Agents; Azathioprine; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Mercaptopurine; Methotrexate; Purines; Risk Factors; Thioguanine; Treatment Outcome	2019
Recent advances using immunomodulators for inflammatory bowel disease. Journal of clinical pharmacology, 2013, Volume: 53, Issue:6 Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate	2013
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? Nature reviews. Gastroenterology & hepatology, 2013, Volume: 10, Issue:6 Topics: Antibodies, Monoclonal; Cost-Benefit Analysis; Crohn Disease; Humans; Methotrexate; Patient Selection; Prognosis; Severity of Illness Index; Steroids; Tumor Necrosis Factor-alpha	2013
Update on pregnancy and breastfeeding in the era of biologics. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Volume: 45, Issue:10 Topics: Adalimumab; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Breast Feeding; Certolizumab Pegol; Colitis, Ulcerative; Contraindications; Crohn Disease; Cyclosporine; Female; Fertility; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Natalizumab; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Tacrolimus	2013
[Rational treatment of Crohn's disease]. MMW Fortschritte der Medizin, 2013, Mar-07, Volume: 155, Issue:4 Topics: Administration, Oral; Administration, Topical; Algorithms; Anti-Inflammatory Agents; Budesonide; Cecum; Crohn Disease; Endoscopy, Gastrointestinal; Humans; Ileum; Immunosuppressive Agents; Methotrexate; Prednisolone; Secondary Prevention; Tumor Necrosis Factor-alpha	2013
Methotrexate: should we start using it in clinical practice? Current drug targets, 2013, Volume: 14, Issue:12 Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction	2013
[Treatment of chronic inflammatory bowel disease based on evidence and according to stage: top down]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:36 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Medical Intervention; Evidence-Based Medicine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome	2013
Comparing medical treatments for Crohn's disease. Journal of comparative effectiveness research, 2013, Volume: 2, Issue:2 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Biological Factors; Budesonide; Crohn Disease; Humans; Intestinal Fistula; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Secondary Prevention	2013
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology, 2013, Volume: 145, Issue:6 Topics: Azathioprine; Crohn Disease; Gastroenterology; Humans; Mercaptopurine; Methotrexate; Remission Induction; Societies, Medical; Tumor Necrosis Factor-alpha; United States	2013
Positioning therapy for Crohn's disease. Current gastroenterology reports, 2014, Volume: 16, Issue:6 Topics: Azathioprine; Crohn Disease; Drug Monitoring; Gastrointestinal Agents; Humans; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha	2014
Can we get more from our current treatments? Best practice & research. Clinical gastroenterology, 2014, Volume: 28, Issue:3 Topics: Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate	2014
Treatment algorithms in Crohn's - up, down or something else? Best practice & research. Clinical gastroenterology, 2014, Volume: 28, Issue:3 Topics: Adalimumab; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Certolizumab Pegol; Crohn Disease; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Polyethylene Glycols; Practice Guidelines as Topic; Tumor Necrosis Factor-alpha	2014
Methotrexate for induction of remission in refractory Crohn's disease. The Cochrane database of systematic reviews, 2014, Aug-06, Issue:8 Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Steroids	2014
Methotrexate for maintenance of remission in Crohn's disease. The Cochrane database of systematic reviews, 2014, Aug-26, Issue:8 Topics: Administration, Oral; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Injections, Intramuscular; Maintenance Chemotherapy; Methotrexate; Randomized Controlled Trials as Topic	2014
Classical and recent advances in the treatment of inflammatory bowel diseases. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2015, Volume: 48, Issue:2 Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell- and Tissue-Based Therapy; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Microbiota; Probiotics; Purines; Quality of Life; Tumor Necrosis Factor-alpha	2015
[First line therapy of inflammatory bowel disease]. La Revue du praticien, 2014, Volume: 64, Issue:9 Topics: Crohn Disease; Digestive System Surgical Procedures; Humans; Immunosuppressive Agents; Methotrexate; Proctocolitis; Purines; Tumor Necrosis Factor-alpha	2014
Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability. Digestive diseases and sciences, 2015, Volume: 60, Issue:8 Topics: Biological Products; Comparative Effectiveness Research; Crohn Disease; Humans; Immunologic Factors; Immunosuppressive Agents; Medication Adherence; Methotrexate; Numbers Needed To Treat; Treatment Outcome	2015
Update on the Medical Management of Crohn's Disease. Current gastroenterology reports, 2015, Volume: 17, Issue:11 Topics: Aminosalicylic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Crohn Disease; Disease Management; Drug Monitoring; Humans; Immunologic Factors; Methotrexate; Purines; Tumor Necrosis Factor-alpha	2015
Methotrexate for the Management of Crohn's Disease in Children. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:1 Topics: Child; Crohn Disease; Disease Management; Humans; Immunosuppressive Agents; Methotrexate; Prospective Studies; Retrospective Studies	2016
New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us? Inflammatory bowel diseases, 2015, Volume: 21, Issue:12 Topics: Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Congresses as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Methotrexate; Review Literature as Topic; Secondary Prevention	2015
Immunomodulators for the treatment of Crohn's disease in adults: optimal use and prospects for future drug treatments. Expert review of clinical immunology, 2016, Volume: 12, Issue:7 Topics: Adalimumab; Adult; Algorithms; Animals; Crohn Disease; Diagnostic Tests, Routine; Humans; Immunologic Factors; Infliximab; Methotrexate	2016
Methotrexate for Inflammatory Bowel Diseases - New Developments. Digestive diseases (Basel, Switzerland), 2016, Volume: 34, Issue:1-2 Topics: Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Methotrexate; Treatment Outcome; Tumor Necrosis Factor-alpha	2016
Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 2016, Volume: 22, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Odds Ratio; Postoperative Complications; Preoperative Period; Retrospective Studies; Sepsis; Tumor Necrosis Factor-alpha; Young Adult	2016
Molluscum contagiosum of the eyelid: case report in a man receiving methotrexate and literature review of molluscum contagiosum in patients who are immunosuppressed secondary to methotrexate or HIV infection. Dermatology online journal, 2016, Mar-16, Volume: 22, Issue:3 Topics: Crohn Disease; Eyelid Diseases; HIV Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Molluscum Contagiosum; Skin; Young Adult	2016
Advances in Pediatric Inflammatory Bowel Disease. Adolescent medicine: state of the art reviews, 2016,Spring, Volume: 27, Issue:1 Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus	2016
The safety of treatment options for pediatric Crohn's disease. Expert opinion on drug safety, 2016, Volume: 15, Issue:10 Topics: Aminosalicylic Acids; Child; Crohn Disease; Disease Progression; Glucocorticoids; Humans; Immunologic Factors; Methotrexate; Tumor Necrosis Factor-alpha	2016
Safety profile of methotrexate in inflammatory bowel disease. Expert opinion on drug safety, 2016, Volume: 15, Issue:10 Topics: Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Steroids	2016
[Second Korean Guidelines for the Management of Crohn's Disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2017, Jan-25, Volume: 69, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Severity of Illness Index; Tumor Necrosis Factor-alpha	2017
Anti-tumor necrosis factor-alpha (TNF-alpha) treatment strategies in Crohn's disease. Recent patents on inflammation & allergy drug discovery, 2007, Volume: 1, Issue:1 Topics: Animals; Antibodies, Monoclonal; Crohn Disease; Drug Therapy, Combination; Humans; Methotrexate; Oligodeoxyribonucleotides; Patents as Topic; Tumor Necrosis Factor-alpha; Vitamin D	2007
[Treatment of Crohn's disease]. Praxis, 2009, Jan-21, Volume: 98, Issue:2 Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Colectomy; Combined Modality Therapy; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Methotrexate	2009
Mild to moderate Crohn's disease: still room for step-up therapies? Digestive diseases (Basel, Switzerland), 2009, Volume: 27, Issue:3 Topics: Antibodies, Monoclonal; Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Infliximab; Methotrexate; Remission Induction	2009
Methotrexate for maintenance of remission in Crohn's disease. The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4 Topics: Administration, Oral; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Injections, Intramuscular; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction	2009
Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies. Inflammatory bowel diseases, 2010, Volume: 16, Issue:7 Topics: Adolescent; Adult; Aged; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult	2010
Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions. American journal of clinical dermatology, 2010, Volume: 11, Issue:3 Topics: Antirheumatic Agents; Crohn Disease; Dermatitis; Diabetes Mellitus; Granuloma; Humans; Methotrexate; Necrobiosis Lipoidica; Neoplasms; Neutrophils; Paraproteinemias; Rheumatoid Nodule; Sarcoidosis; Xanthomatosis	2010
Preparing the patient for immunosuppressive therapy. Current gastroenterology reports, 2010, Volume: 12, Issue:6 Topics: Algorithms; Colitis, Ulcerative; Counseling; Crohn Disease; Glucocorticoids; Humans; Immunization Schedule; Immunosuppressive Agents; Medical History Taking; Mercaptopurine; Methotrexate; Methyltransferases; Patient Selection; Tumor Necrosis Factor-alpha	2010
The safety and tolerability of methotrexate for treating patients with Crohn's disease. Journal of clinical gastroenterology, 2011, Volume: 45, Issue:7 Topics: Adult; Crohn Disease; Female; Humans; Immunosuppressive Agents; Liver Diseases; Male; Methotrexate; Remission Induction; Retrospective Studies; Treatment Outcome	2011
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. The American journal of gastroenterology, 2011, Volume: 106, Issue:4 Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intramuscular; Mercaptopurine; Methotrexate; Remission Induction; Secondary Prevention; Treatment Failure	2011
Update on the management of Crohn's disease. Current gastroenterology reports, 2011, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Budesonide; Crohn Disease; Humans; Immunologic Factors; Immunosuppressive Agents; Mesalamine; Methotrexate; Natalizumab; Sulfasalazine; Tumor Necrosis Factor-alpha	2011
Medical management of Crohn's disease. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:16 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biological Products; Bone Marrow Transplantation; Budesonide; Crohn Disease; Humans; Immunosuppressive Agents; Intestines; Methotrexate; Purines; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha	2011
[Epidemiology, predictors and clinical aspects of loss of response to biological therapy]. Orvosi hetilap, 2012, Feb-05, Volume: 153, Issue:5 Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Drug Tolerance; Gastrointestinal Agents; Humans; Immunologic Factors; Immunotherapy; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Risk Factors; Treatment Failure; Tumor Necrosis Factor-alpha	2012
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:10 Topics: Antibodies, Monoclonal; Azathioprine; Biotransformation; Crohn Disease; Drug Hypersensitivity; Drug Interactions; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Humans; Immunologic Factors; Infliximab; Mercaptopurine; Methotrexate; Patient Selection; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Precision Medicine; Purine-Pyrimidine Metabolism, Inborn Errors; Risk Assessment; Risk Factors; Tumor Necrosis Factor-alpha	2012
Randomized controlled trials in maintenance of remission in Crohn's disease. Reviews on recent clinical trials, 2012, Volume: 7, Issue:4 Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Budesonide; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction; Salicylates	2012
Methotrexate for induction of remission in refractory Crohn's disease. The Cochrane database of systematic reviews, 2012, Dec-12, Volume: 12 Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Steroids	2012
Methotrexate: underused and ignored? Digestive diseases (Basel, Switzerland), 2012, Volume: 30 Suppl 3 Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Methotrexate; Patient Preference; Treatment Outcome	2012
[Drug therapy of Crohn disease]. Duodecim; laaketieteellinen aikakauskirja, 2001, Volume: 117, Issue:8 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Secondary Prevention; Treatment Outcome	2001
Advances in medical therapy for Crohn's disease. Current gastroenterology reports, 2002, Volume: 4, Issue:6 Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Treatment Outcome	2002
Methotrexate for induction of remission in refractory Crohn's disease. The Cochrane database of systematic reviews, 2003, Issue:1 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction	2003
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy]. Der Radiologe, 2003, Volume: 43, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Cyclosporins; Diagnosis, Differential; Gastrointestinal Agents; Humans; Ileostomy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Meta-Analysis as Topic; Methotrexate; Parenteral Nutrition; Prednisolone; Quality of Life; Time Factors; Ultrasonography	2003
Methotrexate: first-line or second-line immunomodulator? European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:3 Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Liver Cirrhosis; Methotrexate	2003
[Pharmacological profile of anti-human TNF alpha monoclonal antibody, infliximab (Remicade)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 121, Issue:1 Topics: Animals; Antibodies, Monoclonal; Arthritis, Rheumatoid; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Infliximab; Methotrexate; Tumor Necrosis Factor-alpha	2003
Low dose methotrexate in inflammatory bowel disease: current status and future directions. The American journal of gastroenterology, 2003, Volume: 98, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Randomized Controlled Trials as Topic; Treatment Outcome	2003
[Treatment of Crohn's disease]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:3 Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Case-Control Studies; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Metronidazole; Osteoporosis; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors	2003
Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn's disease. The British journal of dermatology, 2003, Volume: 149, Issue:1 Topics: Adult; Antibodies, Monoclonal; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Mouth Mucosa; Stomatitis; Vulvitis	2003
How effective are the usual treatments for Crohn's disease? Alimentary pharmacology & therapeutics, 2004, Jul-15, Volume: 20, Issue:2 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Humans; Infliximab; Mercaptopurine; Methotrexate; Randomized Controlled Trials as Topic	2004
Review article: chronic active disease and maintaining remission in Crohn's disease. Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chronic Disease; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prognosis; Steroids; Thalidomide	2004
[Chronic inflammatory bowel diseases]. Deutsche medizinische Wochenschrift (1946), 2004, Oct-15, Volume: 129, Issue:42 Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography	2004
Methotrexate for induction of remission in refractory Crohn's disease. The Cochrane database of systematic reviews, 2005, Jan-25, Issue:1 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction	2005
Can we alter the natural history of Crohn disease in children? Journal of pediatric gastroenterology and nutrition, 2005, Volume: 40, Issue:3 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Child; Crohn Disease; Disease-Free Survival; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate	2005
Low-dose oral methotrexate for maintaining Crohn's disease remission: where we stand. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:9 Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Intestinal Absorption; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction	2005
[Crohn's disease--standards of treatment 2004]. Praxis, 2005, Oct-12, Volume: 94, Issue:41 Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Algorithms; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Practice Guidelines as Topic; Prognosis; Remission Induction; Risk Factors; Time Factors	2005
Pharmacogenetics in inflammatory bowel disease. World journal of gastroenterology, 2006, Jun-21, Volume: 12, Issue:23 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome	2006
Conventional therapy for Crohn's disease. World journal of gastroenterology, 2006, Aug-14, Volume: 12, Issue:30 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Nutrition Therapy; Randomized Controlled Trials as Topic; Remission Induction	2006
[Medical therapy of inflammatory bowel diseases: Crohn's disease]. Orvosi hetilap, 2007, Jun-17, Volume: 148, Issue:24 Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Crohn Disease; Fistula; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Severity of Illness Index	2007
Review article: the evidence base for interventions used to maintain remission in Crohn's disease. Alimentary pharmacology & therapeutics, 2008, Jan-01, Volume: 27, Issue:1 Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Enteral Nutrition; Fatty Acids, Omega-3; Humans; Infliximab; Mesalamine; Methotrexate; Natalizumab; Probiotics; Randomized Controlled Trials as Topic	2008
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective. The Gastroenterologist, 1995, Volume: 3, Issue:2 Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; History, 20th Century; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications	1995
Maintenance of symptomatic remission in patients with Crohn's disease. Mayo Clinic proceedings, 1993, Volume: 68, Issue:12 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine	1993
Medical management of patients with difficult-to-treat inflammatory bowel disease. The Netherlands journal of medicine, 1994, Volume: 45, Issue:2 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole	1994
Immunosuppressive drugs in Crohn's disease. The Gastroenterologist, 1994, Volume: 2, Issue:3 Topics: Azathioprine; Crohn Disease; Cyclosporins; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Remission Induction	1994
Newer treatments for inflammatory bowel disease. Primary care, 1996, Volume: 23, Issue:3 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena	1996
[Drug treatment of Crohn's disease]. Nederlands tijdschrift voor geneeskunde, 1998, May-23, Volume: 142, Issue:21 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Protocols; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Prednisone; Remission Induction; Treatment Outcome	1998
Immunosuppressive drugs in the treatment of Crohn's disease. The European journal of surgery = Acta chirurgica, 1998, Volume: 164, Issue:12 Topics: Azathioprine; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome	1998
Medical therapy for inflammatory bowel disease. Gastroenterology clinics of North America, 1999, Volume: 28, Issue:2 Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids	1999
[Recent progress in therapy of inflammatory bowel diseases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Sep-10, Volume: 88, Issue:9 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids	1999
Clinical pharmacology of inflammatory bowel disease therapies. Current gastroenterology reports, 2000, Volume: 2, Issue:6 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Methotrexate; Pharmacogenetics; Receptors, Glucocorticoid	2000
Conventional treatment of Crohn's disease: objectives and outcomes. Inflammatory bowel diseases, 2001, Volume: 7 Suppl 1 Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome	2001
Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease. Inflammatory bowel diseases, 2001, Volume: 7 Suppl 1 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Etanercept; Female; Gastrointestinal Agents; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Receptors, Tumor Necrosis Factor; Thalidomide; Treatment Outcome	2001
Management of fistulas in patients with Crohn's disease: antibiotic to antibody. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2001, Volume: 15, Issue:11 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mercaptopurine; Methotrexate; Rectal Fistula; Thalidomide	2001
Maintenance drugs for inflammatory bowel disease. Drug and therapeutics bulletin, 2001, Volume: 39, Issue:12 Topics: Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Infliximab; Methotrexate; Treatment Outcome	2001
Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease. Pharmacotherapy, 2002, Volume: 22, Issue:5 Topics: Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Secondary Prevention	2002
[Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings]. Revue medicale de Liege, 1992, Volume: 47, Issue:11 Topics: Antineoplastic Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Methotrexate	1992
[Immunosuppressive treatment and Crohn's disease]. Revue medicale de Liege, 1991, Volume: 46, Issue:1 Topics: Adrenal Cortex Hormones; Azathioprine; Crohn Disease; Cyclosporins; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Opportunistic Infections	1991
Cytotoxic drugs in treatment of nonmalignant diseases. Annals of internal medicine, 1972, Volume: 76, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Granulomatosis with Polyangiitis; Hepatitis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Infections; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Ophthalmia, Sympathetic; Psoriasis; Thioguanine; Uveitis	1972
Immunosuppressive therapy. 1. The New England journal of medicine, 1972, Aug-03, Volume: 287, Issue:5 Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic	1972

Trials

35 trial(s) available for methotrexate and Colitis, Granulomatous

Article	Year
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial. The lancet. Gastroenterology & hepatology, 2023, Volume: 8, Issue:4 Topics: Adalimumab; Adolescent; Adult; C-Reactive Protein; Crohn Disease; Female; Humans; Male; Methotrexate; Netherlands	2023
Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course. BMJ open, 2020, 07-01, Volume: 10, Issue:7 Topics: Adalimumab; Adolescent; Anti-Inflammatory Agents; Azathioprine; Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction	2020
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX. The American journal of gastroenterology, 2021, 01-01, Volume: 116, Issue:1 Topics: Adult; Azathioprine; Colon; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Ileum; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Rectum; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult	2021
Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease. Journal of Crohn's & colitis, 2018, Apr-27, Volume: 12, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biological Products; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Intestinal Mucosa; Male; Mercaptopurine; Methotrexate; Retrospective Studies; Symptom Flare Up; Time Factors; Tumor Necrosis Factor-alpha; Wound Healing; Young Adult	2018
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs. Drug safety, 2019, Volume: 42, Issue:6 Topics: Adult; Antibodies, Monoclonal; Arthritis, Psoriatic; Crohn Disease; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome; Ustekinumab	2019
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. Gastroenterology, 2014, Volume: 146, Issue:3 Topics: Adult; Antibodies, Monoclonal; C-Reactive Protein; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infliximab; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome	2014
Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease. Journal of pediatric gastroenterology and nutrition, 2015, Volume: 60, Issue:5 Topics: Adolescent; Azathioprine; Child; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Methotrexate; Remission Induction; Severity of Illness Index	2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial. Lancet (London, England), 2015, Nov-07, Volume: 386, Issue:10006 Topics: Adalimumab; Adult; Antimetabolites; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Infliximab; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Tumor Necrosis Factor-alpha	2015
Does methotrexate induce mucosal healing in Crohn's disease? Inflammatory bowel diseases, 2010, Volume: 16, Issue:3 Topics: Adult; Aged; Crohn Disease; Female; Humans; Immunosuppressive Agents; Intestinal Mucosa; Male; Methotrexate; Wound Healing; Young Adult	2010
Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab. Alimentary pharmacology & therapeutics, 2011, Volume: 33, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Azathioprine; Colonoscopy; Crohn Disease; Epidemiologic Methods; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Methotrexate; Middle Aged; Treatment Outcome; Wound Healing; Young Adult	2011
Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series. Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:6 Topics: Abdominal Abscess; Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; C-Reactive Protein; Crohn Disease; Disease Susceptibility; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infliximab; Intestinal Fistula; Male; Methotrexate; Prednisone; Tuberculosis, Meningeal; Tumor Necrosis Factor-alpha	2011
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. Journal of Crohn's & colitis, 2013, Volume: 7, Issue:8 Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biphenyl Compounds; Blood Sedimentation; C-Reactive Protein; Colitis, Ulcerative; Crohn Disease; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Feces; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Intention to Treat Analysis; Leukocyte L1 Antigen Complex; Male; Methotrexate; Middle Aged; Oxidoreductases Acting on CH-CH Group Donors; Prednisolone; Remission Induction; Severity of Illness Index; Young Adult	2013
Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease. Alimentary pharmacology & therapeutics, 2003, Jul-01, Volume: 18, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Adult; Arthritis, Rheumatoid; Biological Availability; Crohn Disease; Cross-Over Studies; Drug Combinations; Female; Folic Acid; Half-Life; Humans; Male; Methotrexate; Middle Aged	2003
Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:9 Topics: Adult; Aged; Antimetabolites; Azathioprine; Crohn Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome	2003
Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:1 Topics: Adult; Antibodies, Monoclonal; Chronic Disease; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Pilot Projects; Prednisolone; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha	2006
Pulse cyclophosphamide therapy for inflammatory bowel disease. World journal of gastroenterology, 2006, Feb-28, Volume: 12, Issue:8 Topics: Adult; Aged; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Pulse Therapy, Drug; Remission Induction	2006
Medical therapy for Crohn's disease: top-down or step-up? Digestive diseases (Basel, Switzerland), 2007, Volume: 25, Issue:3 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Biomarkers; Crohn Disease; Denmark; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Remission Induction; Risk Factors; United States	2007
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet (London, England), 2008, Feb-23, Volume: 371, Issue:9613 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Belgium; Chi-Square Distribution; Crohn Disease; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Netherlands; Statistics, Nonparametric; Treatment Outcome	2008
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology, 2008, Volume: 134, Issue:7 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Belgium; C-Reactive Protein; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; France; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Intestinal Mucosa; Male; Mercaptopurine; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome	2008
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. The New England journal of medicine, 1995, Feb-02, Volume: 332, Issue:5 Topics: Adult; Crohn Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Methotrexate; Orosomucoid; Remission, Spontaneous; Treatment Outcome	1995
[Methotrexate as possible treatment in refractory chronic inflammatory intestinal disease]. Nederlands tijdschrift voor geneeskunde, 1994, Dec-17, Volume: 138, Issue:51 Topics: Adolescent; Adult; Colitis; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Female; Humans; Ileitis; Male; Methotrexate; Middle Aged; Treatment Outcome	1994
Low-dose oral methotrexate in refractory inflammatory bowel disease. Digestive diseases and sciences, 1993, Volume: 38, Issue:10 Topics: Administration, Oral; Adult; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Pilot Projects; Prednisone; Time Factors; Treatment Outcome	1993
Methotrexate for the treatment of refractory Crohn's disease. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:3 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antimetabolites; Crohn Disease; Drug Resistance; Female; Humans; Injections, Intramuscular; Male; Methotrexate; Recurrence	1996
[Methotrexate in therapy of chronic inflammatory bowel diseases]. Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:7 Topics: Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Intestinal Mucosa; Methotrexate; Prednisone; Prospective Studies	1996
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial. The American journal of gastroenterology, 1997, Volume: 92, Issue:12 Topics: Abdominal Pain; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chronic Disease; Crohn Disease; Double-Blind Method; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Status; Humans; Immunosuppressive Agents; Israel; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Placebos; Recurrence; Remission Induction; Treatment Outcome	1997
Methotrexate in patients with Crohn's disease after 6-mercaptopurine. The Journal of pediatrics, 1998, Volume: 132, Issue:5 Topics: Adolescent; Child; Child, Preschool; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Mercaptopurine; Methotrexate; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Treatment Outcome	1998
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:12 Topics: Adult; Aged; Antirheumatic Agents; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Inflammation; Male; Methotrexate; Middle Aged; Single-Blind Method; Time Factors; Treatment Outcome	1999
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. The New England journal of medicine, 2000, Jun-01, Volume: 342, Issue:22 Topics: Adult; Crohn Disease; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intramuscular; Male; Methotrexate; Prednisone; Recurrence; Remission Induction	2000
Methotrexate in Crohn's disease: long-term efficacy and toxicity. The American journal of gastroenterology, 2000, Volume: 95, Issue:7 Topics: Adolescent; Adult; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Remission Induction; Time Factors	2000
[Crohn's disease: prevention of relapse with methotrexate or growth hormone]. Presse medicale (Paris, France : 1983), 2000, Oct-14, Volume: 29, Issue:30 Topics: Adult; Aged; Crohn Disease; Female; Growth Hormone; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome	2000
Methotrexate for the maintenance of remission in Crohn's disease. Gastroenterology, 2001, Volume: 120, Issue:6 Topics: Crohn Disease; Double-Blind Method; Humans; Methotrexate; Prospective Studies	2001
[Sustaining remission in Crohn disease with methotrexate--a placebo controlled study]. Zeitschrift fur Gastroenterologie, 2001, Volume: 39, Issue:3 Topics: Crohn Disease; Double-Blind Method; Humans; Injections, Intramuscular; Methotrexate; Recurrence	2001
[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate]. Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:1 Topics: Adult; Azathioprine; Cohort Studies; Crohn Disease; Female; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Treatment Failure	2002
[Methotrexate treatment in Crohn disease]. Gastroenterologie clinique et biologique, 1992, Volume: 16, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Crohn Disease; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Methotrexate; Retrospective Studies; Time Factors	1992
Immunosuppressive therapy. 1. The New England journal of medicine, 1972, Aug-03, Volume: 287, Issue:5 Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic	1972

Other Studies

240 other study(ies) available for methotrexate and Colitis, Granulomatous

Article	Year
Triple therapy with adalimumab, ustekinumab and methotrexate for induction of remission in moderate to severe ileocolonic Crohn's disease with upper gastrointestinal involvement in a biologic-experienced individual. BMJ case reports, 2021, Oct-13, Volume: 14, Issue:10 Topics: Adalimumab; Biological Products; Crohn Disease; Humans; Infliximab; Male; Methotrexate; Remission Induction; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab	2021
Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany. Digestive diseases (Basel, Switzerland), 2022, Volume: 40, Issue:6 Topics: Aged; Antibody Formation; Azathioprine; Cohort Studies; COVID-19; COVID-19 Vaccines; Crohn Disease; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Integrins; Male; Methotrexate; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers; Tumor Necrosis Factor-alpha	2022
Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2022, Volume: 33, Issue:2 Topics: Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha	2022
Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease. Journal of Crohn's & colitis, 2022, Sep-08, Volume: 16, Issue:9 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Retrospective Studies; Thioguanine; Treatment Outcome	2022
Methotrexate for Primary Maintenance Therapy in Mild-to-Moderate Crohn Disease in Children. Journal of pediatric gastroenterology and nutrition, 2022, 09-01, Volume: 75, Issue:3 Topics: Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Remission Induction; Treatment Outcome; Tumor Necrosis Factor Inhibitors	2022
Revisiting Methotrexate Therapy for Pediatric Crohn Disease. Journal of pediatric gastroenterology and nutrition, 2022, 09-01, Volume: 75, Issue:3 Topics: Child; Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Retrospective Studies	2022
Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2022, Volume: 41, Issue:4 Topics: Adult; Azathioprine; Constriction, Pathologic; Crohn Disease; Developing Countries; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Young Adult	2022
Methotrexate for recalcitrant cutaneous Crohn's disease: a dermatology-based case series with emphasis on outcomes. International journal of dermatology, 2023, Volume: 62, Issue:4 Topics: Crohn Disease; Dermatology; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Skin Diseases	2023
Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease. Current medical research and opinion, 2023, Volume: 39, Issue:1 Topics: Adalimumab; Biological Factors; Biological Products; Child; Colitis, Ulcerative; Crohn Disease; Humans; Infliximab; Methotrexate; Tumor Necrosis Factor Inhibitors	2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics. Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2 Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Disease; Etanercept; Humans; Inflammatory Bowel Diseases; Leflunomide; Methotrexate; Retrospective Studies; Sulfasalazine	2023
Treatment withdrawal in Crohn's disease: slowly becoming clearer. The lancet. Gastroenterology & hepatology, 2023, Volume: 8, Issue:3 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate	2023
The Effectiveness and Safety of Methotrexate as the First-Line Immunomodulator of Maintenance Therapy in Pediatric Crohn Disease. Journal of pediatric gastroenterology and nutrition, 2023, 05-01, Volume: 76, Issue:5 Topics: Adult; Child; Crohn Disease; Drug-Related Side Effects and Adverse Reactions; Humans; Immunologic Factors; Immunosuppressive Agents; Infant, Newborn; Methotrexate; Remission Induction; Retrospective Studies; Treatment Outcome	2023
Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports. Journal of medical case reports, 2023, Mar-01, Volume: 17, Issue:1 Topics: Adult; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Sulfasalazine	2023
Combination therapy with methotrexate in paediatric Crohn's disease. Nature reviews. Gastroenterology & hepatology, 2023, Volume: 20, Issue:6 Topics: Child; Combined Modality Therapy; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Methotrexate	2023
Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort. Journal of Crohn's & colitis, 2023, Nov-08, Volume: 17, Issue:10 Topics: Adult; Biological Products; Child; Crohn Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Steroids	2023
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease. Alimentary pharmacology & therapeutics, 2023, Volume: 58, Issue:11-12 Topics: Adult; Aged; Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Crohn Disease; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome	2023
Psoriasis paradox-infliximab-induced psoriasis in a patient with Crohn's disease: a case report and mini-review. The Journal of international medical research, 2023, Volume: 51, Issue:9 Topics: Autoimmune Diseases; Crohn Disease; Humans; Infliximab; Methotrexate; Psoriasis	2023
Recurrence of Metastatic Crohn's Disease after Surgical Resection. Skinmed, 2023, Volume: 21, Issue:5 Topics: Abscess; Adult; Crohn Disease; Female; Humans; Infliximab; Mercaptopurine; Methotrexate; Neoplasms; Recurrence	2023
Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's disease. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:11-12 Topics: Adalimumab; Adolescent; Adult; Asia; Crohn Disease; Databases, Factual; Female; Humans; Infliximab; Male; Methotrexate; Recurrence; Tumor Necrosis Factor-alpha; Withholding Treatment; Young Adult	2019
Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment. PloS one, 2020, Volume: 15, Issue:1 Topics: Adalimumab; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Female; Health Surveys; Humans; Immunosuppressive Agents; Male; Methotrexate; Network Meta-Analysis; Patient Preference; Prednisone; Young Adult	2020
Primary Cutaneous Follicle Center Lymphoma in a 16-Year-old boy With Crohn Disease Exposed to Infliximab and Methotrexate. Journal of pediatric gastroenterology and nutrition, 2020, Volume: 70, Issue:2 Topics: Adolescent; Crohn Disease; Humans; Infliximab; Lymphoma, Follicular; Male; Methotrexate; Skin Neoplasms	2020
Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease. Gastroenterology, 2020, Volume: 158, Issue:8 Topics: Adrenal Cortex Hormones; Aortography; Chest Pain; Child; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Imaging; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Takayasu Arteritis; Treatment Outcome; Tumor Necrosis Factor Inhibitors	2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications. Journal of Crohn's & colitis, 2020, Oct-05, Volume: 14, Issue:10 Topics: Adalimumab; Adult; Azathioprine; Biological Products; Canada; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Infliximab; Male; Methotrexate; Outcome and Process Assessment, Health Care; Patient Selection; Practice Patterns, Physicians'; Treatment Failure; Tumor Necrosis Factor Inhibitors	2020
Noninvasive assessment of liver fibrosis in Crohn's disease patients exposed to methotrexate. European journal of gastroenterology & hepatology, 2021, 06-01, Volume: 33, Issue:6 Topics: Aspartate Aminotransferases; Biopsy; Crohn Disease; Cross-Sectional Studies; Elasticity Imaging Techniques; Humans; Liver Cirrhosis; Methotrexate; Prospective Studies	2021
Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study. Journal of Crohn's & colitis, 2021, Apr-06, Volume: 15, Issue:4 Topics: Adalimumab; Adolescent; Azathioprine; Child; Crohn Disease; Denmark; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunologic Factors; Infliximab; Male; Mercaptopurine; Methotrexate; Treatment Failure; Tumor Necrosis Factor-alpha; Young Adult	2021
Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:9 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Registries; Remission Induction; Retrospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha	2021
Editorial: methotrexate in patients with Crohn's disease refractory to anti-TNF therapy-moving backwards yet forward? Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:8 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Registries; Tumor Necrosis Factor-alpha	2021
Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases. Chest, 2022, Volume: 161, Issue:1 Topics: Adult; Amyloidosis; Calcinosis; Crohn Disease; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Laryngoscopy; Laryngostenosis; Male; Methotrexate; Middle Aged; Polychondritis, Relapsing; Retrospective Studies; Sarcoidosis; Skin Diseases, Vesiculobullous; Tomography, X-Ray Computed; Tracheal Stenosis	2022
Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up. Digestive diseases and sciences, 2017, Volume: 62, Issue:11 Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Crohn Disease; Databases, Factual; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Infliximab; Kaplan-Meier Estimate; Male; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Remission Induction; Risk Factors; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult	2017
Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients. Digestion, 2017, Volume: 96, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Intestinal Mucosa; Longitudinal Studies; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Wound Healing; Young Adult	2017
Anti-TNF Re-induction Is as Effective, Simpler, and Cheaper Compared With Dose Interval Shortening for Secondary Loss of Response in Crohn's Disease. Journal of Crohn's & colitis, 2018, Feb-28, Volume: 12, Issue:3 Topics: Adalimumab; Adult; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Feces; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Leukocyte L1 Antigen Complex; Maintenance Chemotherapy; Male; Methotrexate; Retreatment; Retrospective Studies; Serum Albumin; Sex Factors; Time Factors; Treatment Failure; Tumor Necrosis Factor-alpha	2018
Effects of Anti-TNF Mediators of inflammation, 2018, Volume: 2018 Topics: Adalimumab; Adrenal Cortex Hormones; Azathioprine; Crohn Disease; Female; Flow Cytometry; Humans; Interleukin-17; Interleukin-22; Interleukins; Male; Methotrexate; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha	2018
The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World. Canadian journal of gastroenterology & hepatology, 2018, Volume: 2018 Topics: Adalimumab; Adolescent; Africa; Asia; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Europe; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infliximab; Internationality; Methotrexate; North America; Oceania; Practice Patterns, Physicians'; South America; Surveys and Questionnaires; Tumor Necrosis Factor-alpha	2018
Painful nonhealing vulvar and perianal erosions. Cutis, 2018, Volume: 101, Issue:6 Topics: Adult; Antirheumatic Agents; Biopsy; Crohn Disease; Diagnosis, Differential; Female; Fissure in Ano; Granuloma; Humans; Infliximab; Methotrexate; Physical Examination; Skin; Treatment Outcome; Vulvar Diseases	2018
Cerebral granulomatosis as a manifestation of Crohn's disease. BMC neurology, 2018, Oct-03, Volume: 18, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Brain Diseases; Crohn Disease; Disease Progression; Female; Granuloma; Humans; Immunosuppressive Agents; Methotrexate; Vasculitis, Central Nervous System	2018
Association of Blepharitis and Ectropion With Tumor Necrosis Factor α Inhibitor Treatment in Crohn Disease. JAMA ophthalmology, 2019, 02-01, Volume: 137, Issue:2 Topics: Adalimumab; Adolescent; Blepharitis; Crohn Disease; Drug Substitution; Ectropion; Enzyme Inhibitors; Gastrointestinal Agents; Humans; Infliximab; Male; Methotrexate; Tumor Necrosis Factor-alpha; Visual Acuity; Withholding Treatment	2019
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:9 Topics: Adalimumab; Adult; Azathioprine; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Digestive System Surgical Procedures; Drug Substitution; Drug Therapy, Combination; Female; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Male; Manitoba; Methotrexate; Prednisone; Proportional Hazards Models; Retrospective Studies; Tumor Necrosis Factor Inhibitors	2019
A single-center experience with methotrexate in the treatment of Chinese Crohn's disease patients. Journal of digestive diseases, 2018, Volume: 19, Issue:12 Topics: Adult; C-Reactive Protein; Crohn Disease; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies	2018
Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease. Digestive diseases and sciences, 2019, Volume: 64, Issue:6 Topics: Adalimumab; Adult; Biological Products; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Methotrexate; Middle Aged; Purines; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Victoria; Wound Healing	2019
Neuroradiological worsening of brain abscess after adalimumab and methotrexate withdrawal: Do not forget Immune Reconstitution Inflammatory Syndrome. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2019, Volume: 62 Topics: Adalimumab; Brain Abscess; Crohn Disease; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged	2019
Predictors for Complicated Disease Course after Stepping Down from Combination to Antitumor Necrosis Factor Alpha Monotherapy in Children with Inflammatory Bowel Disease. Digestion, 2020, Volume: 101, Issue:2 Topics: Adalimumab; Adolescent; Child; Colitis, Ulcerative; Crohn Disease; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Purines; Retrospective Studies; Risk Factors; Treatment Outcome; Tumor Necrosis Factor Inhibitors	2020
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study. The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:5 Topics: Adalimumab; Adult; Age Factors; Antibodies; Azathioprine; Cohort Studies; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin; Smoking; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Young Adult	2019
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:9 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Canada; Crohn Disease; Gastroenterology; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Methotrexate; Prednisolone; Societies, Medical; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab	2019
Methotrexate for inflammatory bowel disease: time for reconsideration. Expert review of gastroenterology & hepatology, 2019, Volume: 13, Issue:5 Topics: Anti-Inflammatory Agents; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Methotrexate; Patient Selection; Remission Induction; Treatment Outcome	2019
Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:10 Topics: Adolescent; Adult; Allopurinol; Beclomethasone; Colitis, Ulcerative; Crohn Disease; Databases, Factual; Female; Humans; Male; Mercaptopurine; Methotrexate; Netherlands; Off-Label Use; Thioguanine; Young Adult	2019
A Novel Manifestation of Prolidase Deficiency in a Toddler Diagnosed With Very-early-onset Crohn Disease. Journal of pediatric gastroenterology and nutrition, 2019, Volume: 69, Issue:3 Topics: Child, Preschool; Colonoscopy; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methotrexate; Prolidase Deficiency; Tacrolimus	2019
Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women. Acta gastro-enterologica Belgica, 2012, Volume: 75, Issue:4 Topics: Adult; Alkaline Phosphatase; Azathioprine; Back Pain; Black People; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Colonoscopy; Crohn Disease; Diarrhea; Female; gamma-Glutamyltransferase; Genetic Predisposition to Disease; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Severity of Illness Index; South Africa; Treatment Outcome; Ursodeoxycholic Acid	2012
Methotrexate for inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:8 Topics: Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate	2013
[Adalimumab vasculitis in a patient with Crohn's disease]. Gastroenterologia y hepatologia, 2013, Volume: 36, Issue:4 Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Middle Aged; Purpura; Tumor Necrosis Factor-alpha; Vasculitis, Leukocytoclastic, Cutaneous	2013
Reply: To PMID 23333660. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:8 Topics: Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate	2013
Treatment of inflammatory bowel disease with methotrexate in clinical practice. Journal of Crohn's & colitis, 2013, Volume: 7, Issue:11 Topics: Adult; Aged; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Patient Safety; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2013
Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. Journal of Crohn's & colitis, 2014, Volume: 8, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Viral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunity, Active; Immunosuppressive Agents; Infliximab; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Male; Mercaptopurine; Methotrexate; Middle Aged; Prospective Studies; Tacrolimus	2014
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease. Gastroenterology, 2014, Volume: 146, Issue:2 Topics: Adalimumab; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child Development; Crohn Disease; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Male; Matched-Pair Analysis; Mercaptopurine; Methotrexate; Propensity Score; Prospective Studies; Severity of Illness Index; Treatment Outcome	2014
Pyoderma gangrenosum and tumor necrosis factor α agents. Cutis, 2013, Volume: 92, Issue:4 Topics: Antibodies, Monoclonal; Crohn Disease; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha	2013
American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology, 2013, Volume: 145, Issue:6 Topics: Azathioprine; Crohn Disease; Gastroenterology; Humans; Mercaptopurine; Methotrexate; Remission Induction; Societies, Medical; Tumor Necrosis Factor-alpha; United States	2013
Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate. Canadian journal of gastroenterology & hepatology, 2014, Volume: 28, Issue:1 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Middle Aged; Time Factors; Treatment Outcome	2014
Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur. Canadian family physician Medecin de famille canadien, 2014, Volume: 60, Issue:1 Topics: Aged; Anti-Infective Agents; Crohn Disease; Diarrhea; Drug Interactions; Female; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate; Mucositis; Pneumonia, Pneumocystis; Prednisone; Stomatitis; Trimethoprim, Sulfamethoxazole Drug Combination	2014
Combination therapy with methotrexate in inflammatory bowel disease: time to COMMIT? Gastroenterology, 2014, Volume: 146, Issue:3 Topics: Antibodies, Monoclonal; Crohn Disease; Female; Humans; Infliximab; Male; Methotrexate	2014
Recurrent Bell's palsy in a patient with Crohn's disease on methotrexate. Journal of clinical gastroenterology, 2014, Volume: 48, Issue:7 Topics: Adult; Bell Palsy; Crohn Disease; Herpes Simplex; Humans; Immunosuppressive Agents; Male; Methotrexate; Recurrence	2014
A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease. Inflammatory bowel diseases, 2014, Volume: 20, Issue:4 Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antibodies, Monoclonal; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Methotrexate; Remission Induction; Retrospective Studies; Tertiary Care Centers; Time Factors; Treatment Failure; Young Adult	2014
[The efficacy and safety of methotrexate in refractory Crohn's disease]. Zhonghua nei ke za zhi, 2014, Volume: 53, Issue:3 Topics: Adolescent; Adult; Crohn Disease; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2014
Limited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence? The clinical respiratory journal, 2015, Volume: 9, Issue:4 Topics: Administration, Intravenous; Crohn Disease; Diagnosis, Differential; Female; Granulomatosis with Polyangiitis; Humans; Infliximab; Methotrexate; Steroids; Treatment Outcome; Young Adult	2015
Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:8 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antimetabolites; Azathioprine; Crohn Disease; Female; Follow-Up Studies; Humans; Infliximab; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Treatment Failure; Withholding Treatment; Young Adult	2014
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Journal of Crohn's & colitis, 2014, Volume: 8, Issue:10 Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Crohn Disease; Enteral Nutrition; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Remission Induction; Thalidomide; Tumor Necrosis Factor-alpha	2014
Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: a real life cohort study. Journal of Crohn's & colitis, 2014, Volume: 8, Issue:11 Topics: Adalimumab; Adult; Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha	2014
Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease. Inflammatory bowel diseases, 2014, Volume: 20, Issue:8 Topics: Adolescent; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methotrexate; Prospective Studies; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome	2014
Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease. Inflammatory bowel diseases, 2014, Volume: 20, Issue:8 Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anal Canal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Secondary Prevention; Young Adult	2014
Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study. Gut, 2015, Volume: 64, Issue:12 Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Body Height; Child; Child Development; Child, Preschool; Crohn Disease; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Methotrexate; Nausea; Propensity Score; Remission Induction; Retrospective Studies; Severity of Illness Index; Time Factors	2015
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease]. Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:1 Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Nausea; Ondansetron	2015
An adolescent girl with Crohn's disease, fever, and sore throat. Pediatric annals, 2015, Volume: 44, Issue:1 Topics: Adenoidectomy; Adolescent; Crohn Disease; Female; Fever; Herpesvirus 4, Human; Humans; Immunocompromised Host; Infectious Mononucleosis; Methotrexate; Pharyngitis; Polymerase Chain Reaction; Tomography, X-Ray Computed; Tonsillectomy; Tonsillitis	2015
Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study. Journal of Crohn's & colitis, 2015, Volume: 9, Issue:4 Topics: Adolescent; Child; Child, Preschool; Crohn Disease; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Methotrexate; Methyltransferases; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome	2015
Vulval Crohn's disease: a clinical study of 22 patients. Journal of Crohn's & colitis, 2015, Volume: 9, Issue:4 Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Child; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Tumor Necrosis Factor-alpha; Vulva; Vulvar Diseases; Young Adult	2015
Successful methotrexate treatment of oesophageal pemphigus vulgaris in an immunosuppressed patient with Crohn's disease. Acta dermato-venereologica, 2015, Volume: 95, Issue:7 Topics: Adult; Crohn Disease; Drug Substitution; Drug Therapy, Combination; Esophageal Diseases; Esophagoscopy; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Pemphigus; Predictive Value of Tests; Remission Induction; Treatment Outcome	2015
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents. Journal of Crohn's & colitis, 2015, Volume: 9, Issue:5 Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cerebrovascular Disorders; Certolizumab Pegol; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Rare Diseases; Retreatment; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult	2015
Addition of an immunomodulator as a rescue therapy for loss of response to adalimumab dose escalation in patients with Crohn's disease. Journal of Crohn's & colitis, 2015, Volume: 9, Issue:7 Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies; Salvage Therapy; Young Adult	2015
Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease. Scandinavian journal of gastroenterology, 2015, Volume: 50, Issue:10 Topics: Azathioprine; Child; Child, Preschool; Cohort Studies; Crohn Disease; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome	2015
Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. European journal of gastroenterology & hepatology, 2015, Volume: 27, Issue:6 Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Body Mass Index; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Fatty Liver; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Ultrasonography; Young Adult	2015
Penile ulceration: a rare manifestation of cutaneous crohn's successfully treated with subcutaneous methotrexate. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:10 Topics: Adult; Crohn Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Penile Diseases; Ulcer	2016
[A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2015, Volume: 66, Issue:4 Topics: Adult; Antibodies, Monoclonal; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Remission Induction; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha	2015
Thromboembolism as an important complication of inflammatory bowel disease. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1 Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis	2016
Hyperacute Methotrexate Pneumonitis in a Patient With Crohn's Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:3 Topics: Crohn Disease; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Pneumonia; Radiography, Thoracic; Tomography, X-Ray Computed	2016
Treatment of metastatic cutaneous Crohn disease with certolizumab. Dermatology online journal, 2015, Nov-18, Volume: 21, Issue:11 Topics: Adult; Certolizumab Pegol; Crohn Disease; Female; Humans; Immunosuppressive Agents; Methotrexate; Skin Diseases; Tumor Necrosis Factor-alpha	2015
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience. Journal of Crohn's & colitis, 2016, Volume: 10, Issue:5 Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2016
European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:7 Topics: Adult; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult	2016
Inflammatory bowel disease in the clinic: Escalation and de-escalation of therapy: A longitudinal case-based discussion. Journal of gastroenterology and hepatology, 2016, Volume: 31 Suppl 1 Topics: Adolescent; Azathioprine; Crohn Disease; Drug Substitution; Drug Therapy, Combination; Enteral Nutrition; Guanine Nucleotides; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, T-Cell; Male; Methotrexate; Recurrence; Remission Induction; Thionucleotides	2016
Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients. Digestive diseases and sciences, 2016, Volume: 61, Issue:11 Topics: Adalimumab; Adult; Cohort Studies; Colectomy; Constriction, Pathologic; Crohn Disease; Delayed Diagnosis; Digestive System Surgical Procedures; Enterostomy; Female; France; Humans; Immunosuppressive Agents; Infliximab; Intestinal Obstruction; Jejunum; Kaplan-Meier Estimate; Male; Methotrexate; Prospective Studies; Risk; Time Factors; Tumor Necrosis Factor-alpha; Young Adult	2016
Methotrexate Polyglutamate Monitoring in Patients With Crohn's Disease. Clinical pharmacology in drug development, 2017, Volume: 6, Issue:3 Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Crohn Disease; Cross-Sectional Studies; Drug Monitoring; Female; Humans; Injections, Subcutaneous; Male; Methotrexate; Middle Aged; Pilot Projects; Polyglutamic Acid; Tandem Mass Spectrometry; Treatment Outcome	2017
Focal autoimmune pancreatitis in a patient with Crohn's disease. Postgraduate medical journal, 2016, Volume: 92, Issue:1094 Topics: Aged; Autoimmune Diseases; Biopsy, Large-Core Needle; Crohn Disease; Endosonography; Female; Humans; Image-Guided Biopsy; Immunosuppressive Agents; Methotrexate; Pancreatitis; Tomography, X-Ray Computed	2016
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. The American journal of gastroenterology, 2016, Volume: 111, Issue:10 Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Follow-Up Studies; France; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Intestinal Neoplasms; Lymphoproliferative Disorders; Male; Mesalamine; Methotrexate; Middle Aged; Myeloproliferative Disorders; Neoplasms; Proportional Hazards Models; Protective Factors; Registries; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha	2016
Mucosal Healing of Pediatric Simple Ulcer Treated With Infliximab and Methotrexate. Journal of pediatric gastroenterology and nutrition, 2018, Volume: 67, Issue:2 Topics: Child, Preschool; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Ileocecal Valve; Infliximab; Male; Methotrexate; Ulcer; Wound Healing	2018
Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate. BMJ case reports, 2016, Aug-29, Volume: 2016 Topics: Contraindications; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Medical Errors; Methotrexate; Middle Aged; Prognosis; Vaccination; Viremia; Yellow Fever	2016
Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases. Digestive diseases and sciences, 2016, Volume: 61, Issue:11 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Child; Cohort Studies; Colectomy; Colitis, Ulcerative; Colonic Pouches; Crohn Disease; Digestive System Surgical Procedures; Enterostomy; Female; Hospitalization; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Methotrexate; Proctocolectomy, Restorative; Prognosis; Retrospective Studies; Young Adult	2016
Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab. The American journal of gastroenterology, 2016, Volume: 111, Issue:12 Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Crohn Disease; Drug Therapy, Combination; Female; Herpes Zoster; Humans; Immunologic Factors; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multivariate Analysis; Opportunistic Infections; Proportional Hazards Models; Risk Factors; Severity of Illness Index; Young Adult	2016
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab. Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:2 Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies; Antibody Formation; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunologic Factors; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Young Adult	2017
Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort. The American journal of gastroenterology, 2017, Volume: 112, Issue:2 Topics: Adalimumab; Adult; Antirheumatic Agents; Azathioprine; Biological Products; Crohn Disease; Digestive System Surgical Procedures; Female; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Infliximab; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Multivariate Analysis; Netherlands; Prednisone; Propensity Score; Proportional Hazards Models; Severity of Illness Index; Young Adult	2017
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study. The American journal of gastroenterology, 2017, Volume: 112, Issue:1 Topics: Adalimumab; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Colitis, Ulcerative; Colon; Constriction, Pathologic; Crohn Disease; Deprescriptions; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ileum; Immunologic Factors; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult	2017
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy. Journal of Crohn's & colitis, 2017, Jun-01, Volume: 11, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult	2017
Overcoming Challenges to Care in the Juvenile Justice System: A Case Study and Commentary. Pediatrics in review, 2017, Volume: 38, Issue:1 Topics: Adalimumab; Adolescent; Criminal Law; Crohn Disease; Delivery of Health Care; Health Services Needs and Demand; Humans; Immunosuppressive Agents; Male; Methotrexate; Pediatrics; Social Justice; Vulnerable Populations	2017
Diet to the Rescue: Cessation of Pharmacotherapy After Initiation of Exclusive Enteral Nutrition (EEN) Followed by Strict and Liberalized Specific Carbohydrate Diet (SCD) in Crohn's Disease. Digestive diseases and sciences, 2017, Volume: 62, Issue:10 Topics: Adolescent; Blood Sedimentation; Crohn Disease; Deprescriptions; Dietary Carbohydrates; Enteral Nutrition; Feces; Humans; Inflammation; Leukocyte L1 Antigen Complex; Male; Methotrexate; Prednisone	2017
Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study. Inflammatory bowel diseases, 2017, Volume: 23, Issue:3 Topics: Adult; Azathioprine; Crohn Disease; Drug Resistance; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Male; Mercaptopurine; Methotrexate; Quality of Life; Research Design; Retrospective Studies; Treatment Outcome; Young Adult	2017
[Biological therapy as treatment of inflammatory bowel diseases]. Ugeskrift for laeger, 2008, Jun-09, Volume: 170, Issue:24 Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome	2008
Patient with severe Crohn's disease became a father while on methotrexate and infliximab therapy. Inflammatory bowel diseases, 2009, Volume: 15, Issue:5 Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Crohn Disease; Fathers; Female; Fertility; Humans; Infant, Newborn; Infliximab; Male; Methotrexate	2009
Is there a role for multidrug therapy in active Crohn's disease? Inflammatory bowel diseases, 2008, Volume: 14 Suppl 2 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome	2008
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis? Inflammatory bowel diseases, 2008, Volume: 14 Suppl 2 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome	2008
Successful implementation of a nurse-led teaching programme to independently administer subcutaneous methotrexate in the community setting to children with Crohn's disease. Alimentary pharmacology & therapeutics, 2009, Volume: 29, Issue:1 Topics: Adolescent; Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Methotrexate; Nurse Clinicians; Parents; Residence Characteristics; Retrospective Studies; Scotland; Treatment Outcome	2009
Methotrexate: the best choice for second-line maintenance treatment in active Crohn's disease? Gastroenterologie clinique et biologique, 2009, Volume: 33, Issue:1 Pt 1 Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction; Tumor Necrosis Factor-alpha	2009
Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease. Digestive diseases and sciences, 2009, Volume: 54, Issue:8 Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Ciprofloxacin; Crohn Disease; Drainage; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Magnetic Resonance Imaging; Male; Methotrexate; Metronidazole; Middle Aged; Predictive Value of Tests; Remission Induction; Retrospective Studies	2009
[Which place for methotrexate in treatment of luminal Crohn's disease?]. Gastroenterologie clinique et biologique, 2009, Volume: 33, Issue:1 Pt 1 Topics: Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Tumor Necrosis Factor-alpha	2009
Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease. Medical science monitor : international medical journal of experimental and clinical research, 2009, Volume: 15, Issue:1 Topics: Antibodies, Monoclonal; Crohn Disease; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methotrexate; Middle Aged	2009
Peripheral neuropathy with infliximab therapy in inflammatory bowel disease. Inflammatory bowel diseases, 2009, Volume: 15, Issue:12 Topics: Antibodies, Monoclonal; Crohn Disease; Exanthema; Female; Gastrointestinal Agents; Humans; Infliximab; Mercaptopurine; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Steroids; Treatment Outcome; Tumor Necrosis Factor-alpha	2009
A 24-year-old pregnant woman with inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2009, Volume: 7, Issue:9 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Breast Feeding; Crohn Disease; Female; Fetus; Humans; Infant, Newborn; Infliximab; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Remission Induction; Risk Assessment; Thalidomide; Young Adult	2009
Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues. Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48, Issue:5 Topics: Administration, Oral; Adolescent; Azathioprine; Child; Crohn Disease; Drug Resistance; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Mercaptopurine; Methotrexate; Remission Induction; Retrospective Studies; Steroids	2009
A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease. Scandinavian journal of clinical and laboratory investigation, 2009, Volume: 69, Issue:6 Topics: Adolescent; Adult; Case-Control Studies; Crohn Disease; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Interleukin-10; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Methotrexate; Middle Aged; Phytohemagglutinins; Tumor Necrosis Factor-alpha; Young Adult	2009
Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease. The American journal of gastroenterology, 2009, Volume: 104, Issue:10 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Case-Control Studies; Comorbidity; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prednisone; Prevalence; Proportional Hazards Models; Steroids; United States	2009
Immunomodulation with methotrexate: underused and undervalued? Digestive diseases (Basel, Switzerland), 2009, Volume: 27, Issue:3 Topics: Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Immune Tolerance; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Methotrexate	2009
Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: report of 2 cases successfully treated with methotrexate. Inflammatory bowel diseases, 2010, Volume: 16, Issue:6 Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Crohn Disease; Female; Humans; Male; Methotrexate; Pityriasis Lichenoides; Tumor Necrosis Factor-alpha	2010
Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination? Inflammatory bowel diseases, 2010, Volume: 16, Issue:8 Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Corticosterone; Crohn Disease; Female; Gastrointestinal Agents; Humans; Infliximab; Latent Tuberculosis; Male; Methotrexate; Radiography; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha	2010
Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails? Reviews on recent clinical trials, 2009, Volume: 4, Issue:3 Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Methotrexate; Polyethylene Glycols; Steroids; Tumor Necrosis Factor-alpha	2009
[Significant changes of pharmacotherapy in gastroenterological rehabilitation of Crohn's disease]. Die Rehabilitation, 2009, Volume: 48, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Products; Combined Modality Therapy; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Germany; Guideline Adherence; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged	2009
A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT. Transfusion medicine (Oxford, England), 2010, Aug-01, Volume: 20, Issue:4 Topics: Acute Disease; Adult; Azathioprine; Blood Donors; Carrier State; Crohn Disease; DNA, Viral; False Negative Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Nucleic Acid Amplification Techniques; Prednisolone; Transfusion Reaction; Viral Load; Viremia	2010
Inadvertent conception during concomitant treatment with infliximab and methotrexate in a patient with Crohn's disease: is the game worth the candle? Inflammatory bowel diseases, 2010, Volume: 16, Issue:10 Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Crohn Disease; Drug Therapy, Combination; Female; Fertilization; Humans; Infliximab; Methotrexate; Pregnancy; Prognosis	2010
[Portal hypertension in patients with inflammatory bowel disease]. Gastroenterologia y hepatologia, 2010, Volume: 33, Issue:4 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Ascites; Crohn Disease; Female; Humans; Hypertension, Portal; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Pseudo-Obstruction; Liver Cirrhosis; Mesalamine; Mesenteric Veins; Methotrexate; Splenomegaly; Thioguanine; Thrombophilia; Varicose Veins	2010
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?]. MMW Fortschritte der Medizin, 2010, Jan-14, Volume: 152, Issue:1-2 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Remission Induction	2010
Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment. Postgraduate medical journal, 2010, Volume: 86, Issue:1014 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Treatment Outcome; Young Adult	2010
Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis. Revista espanola de enfermedades digestivas, 2010, Volume: 102, Issue:2 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Aorta, Abdominal; Aortitis; Azathioprine; Crohn Disease; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Angiography; Mesalamine; Methotrexate; Methylprednisolone; Takayasu Arteritis; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Young Adult	2010
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy. Gut, 2010, Volume: 59, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate; Prospective Studies; Registries; Tumor Necrosis Factor-alpha; Young Adult	2010
Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study. Inflammatory bowel diseases, 2011, Volume: 17, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal; Anus Diseases; Combined Modality Therapy; Crohn Disease; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Perineum; Retrospective Studies; Treatment Outcome; Young Adult	2011
Dacryoadenitis, an extra-intestinal manifestation of Crohn's disease. The American journal of gastroenterology, 2010, Volume: 105, Issue:8 Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biopsy; Crohn Disease; Dacryocystitis; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Methotrexate	2010
A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease. Journal of pediatric gastroenterology and nutrition, 2010, Volume: 51, Issue:6 Topics: Antibodies, Monoclonal; Child; Crohn Disease; Drug Tolerance; Female; Humans; Infliximab; Leukopenia; Male; Mercaptopurine; Methotrexate; Methyltransferases; Nausea; Outcome Assessment, Health Care; Patient Compliance; Remission Induction; Retrospective Studies; Transaminases	2010
Facial basal cell carcinoma in a young patient with Crohn disease. The Journal of craniofacial surgery, 2010, Volume: 21, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Basal Cell; Crohn Disease; Facial Neoplasms; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Nose Neoplasms; Prednisolone	2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. Journal of Crohn's & colitis, 2010, Volume: 4, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Child; Constriction, Pathologic; Crohn Disease; Diet Therapy; Humans; Immunosuppressive Agents; Infliximab; Intestines; Methotrexate; Purines; Recurrence; Remission Induction; Tumor Necrosis Factor-alpha	2010
Methotrexate-induced pneumonitis in a patient with Crohn's disease. Journal of Crohn's & colitis, 2010, Volume: 4, Issue:2 Topics: Adult; Crohn Disease; Female; Humans; Immunosuppressive Agents; Methotrexate; Pneumonia; Treatment Outcome	2010
Methotrexate dose in current ECCO consensus on Crohn's disease. Journal of Crohn's & colitis, 2010, Volume: 4, Issue:4 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate	2010
Improvement in growth of children with Crohn disease following anti-TNF-α therapy can be independent of pubertal progress and glucocorticoid reduction. Journal of pediatric gastroenterology and nutrition, 2011, Volume: 52, Issue:1 Topics: Adolescent; Antibodies, Monoclonal; Body Height; Child; Crohn Disease; Female; Gastrointestinal Agents; Glucocorticoids; Growth; Humans; Infliximab; Logistic Models; Male; Methotrexate; Multivariate Analysis; Puberty; Retrospective Studies; Statistics, Nonparametric	2011
Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn's disease: a US national practice survey comparing experts and non-experts. Digestive diseases and sciences, 2011, Volume: 56, Issue:4 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Crohn Disease; Gastrointestinal Agents; Health Care Surveys; Humans; Infliximab; Methotrexate; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; United States	2011
Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient. Rheumatology (Oxford, England), 2011, Volume: 50, Issue:4 Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Crohn Disease; Drug Therapy, Combination; Eye; Humans; Infliximab; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Risk Factors; Treatment Outcome; Withholding Treatment	2011
Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. Inflammatory bowel diseases, 2011, Volume: 17, Issue:12 Topics: Adolescent; Canada; Child; Child, Preschool; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Maximum Tolerated Dose; Methotrexate; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome	2011
Clinical course of Crohn's disease following treatment of lymphoma. Inflammatory bowel diseases, 2011, Volume: 17, Issue:6 Topics: Adolescent; Adult; Antineoplastic Agents; Child; Crohn Disease; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2011
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. Journal of Crohn's & colitis, 2011, Volume: 5, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus	2011
Short-course ondansetron for the prevention of methotrexate-induced nausea in children with Crohn disease. Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53, Issue:4 Topics: Adolescent; Case-Control Studies; Child; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Nausea; Ondansetron; Ontario; Premedication; Retrospective Studies; Treatment Outcome	2011
Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series. Inflammatory bowel diseases, 2012, Volume: 18, Issue:8 Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Colitis; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Prognosis; Remission Induction; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult	2012
Treatment of Crohn's disease with cannabis: an observational study. The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:8 Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cannabis; Crohn Disease; Digestive System Surgical Procedures; Drug Utilization; Female; Humans; Immunosuppressive Agents; Male; Mesalamine; Methotrexate; Middle Aged; Phytotherapy; Retrospective Studies; Severity of Illness Index; Tumor Necrosis Factor-alpha	2011
Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases. Archives of dermatology, 2011, Volume: 147, Issue:10 Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Alefacept; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Crohn Disease; Cyclosporine; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Middle Aged; Mycophenolic Acid; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Treatment Outcome; Ustekinumab	2011
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:5 Topics: Adolescent; Adult; Age Factors; Anal Canal; Analysis of Variance; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Constriction, Pathologic; Crohn Disease; Cyclosporine; Female; Hong Kong; Hospitalization; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Sex Factors; Smoking; Steroids; Tumor Necrosis Factor Inhibitors; Victoria; Young Adult	2012
Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience. Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:2 Topics: Adolescent; Adult; Cohort Studies; Crohn Disease; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Remission Induction; Time Factors; Treatment Outcome; Young Adult	2012
Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial. Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:5 Topics: Adult; Analysis of Variance; Chi-Square Distribution; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Elasticity Imaging Techniques; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis; Logistic Models; Male; Methotrexate; Middle Aged	2012
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. The American journal of gastroenterology, 2012, Volume: 107, Issue:4 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chi-Square Distribution; Cohort Studies; Crohn Disease; Female; Gastrointestinal Agents; Humans; Hungary; Immunosuppressive Agents; Incidence; Infliximab; Logistic Models; Male; Mercaptopurine; Mesalamine; Methotrexate; Phenotype; Proportional Hazards Models; Retrospective Studies; Steroids; Sulfasalazine; Surveys and Questionnaires	2012
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience. Journal of Crohn's & colitis, 2012, Volume: 6, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Male; Methotrexate; Multivariate Analysis; Phenotype; Remission Induction; Retrospective Studies; Severity of Illness Index; Sex Factors; Treatment Outcome; Young Adult	2012
Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Biomarkers; C-Reactive Protein; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Membrane Glycoproteins; Methotrexate; Prospective Studies; Receptors, Immunologic; Serum Albumin; Severity of Illness Index; Triggering Receptor Expressed on Myeloid Cells-1; Young Adult	2012
[Guidelines for the management of Crohn's disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 59, Issue:2 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine	2012
Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on Crohn's disease: a real-life survey in Spain. Journal of Crohn's & colitis, 2012, Volume: 6, Issue:7 Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Gastroenterology; Glucocorticoids; Guideline Adherence; Hepatitis B; Humans; Immunosuppressive Agents; Infliximab; Influenza, Human; Methotrexate; Practice Guidelines as Topic; Prospective Studies; Spain; Specialization; Surveys and Questionnaires; Vaccination	2012
The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD). Journal of Crohn's & colitis, 2012, Volume: 6, Issue:3 Topics: Adalimumab; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Body Height; Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Puberty; Remission Induction; Statistics, Nonparametric; Time Factors; Tumor Necrosis Factor-alpha	2012
Vaccinating patients with inflammatory bowel disease--primum non nocere. Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:8-9 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Female; Guideline Adherence; Humans; Immunosuppressive Agents; Infliximab; Male; Mass Screening; Methotrexate; Middle Aged; Practice Guidelines as Topic; Prednisolone; Vaccination	2012
Growth in children receiving contemporary disease specific therapy for Crohn's disease. Archives of disease in childhood, 2012, Volume: 97, Issue:8 Topics: Adolescent; Azathioprine; Body Height; Child; Child Development; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Puberty; Retrospective Studies; Young Adult	2012
Intolerance of folic acid in a patient receiving methotrexate for Crohn's disease. Journal of Crohn's & colitis, 2012, Volume: 6, Issue:9 Topics: Adult; Crohn Disease; Drug Overdose; Female; Folic Acid; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Methotrexate; Nausea; Vitamin B Complex; Young Adult	2012
Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease. Journal of pediatric gastroenterology and nutrition, 2012, Volume: 55, Issue:6 Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Body Height; Body Mass Index; Child; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Female; Growth; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Severity of Illness Index; Sex Factors; Treatment Outcome	2012
Vasculitis associated with tumor necrosis factor-α inhibitors. Mayo Clinic proceedings, 2012, Volume: 87, Issue:8 Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Etanercept; Female; Glucocorticoids; Hematuria; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyneuropathies; Prednisone; Proteinuria; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rituximab; Tumor Necrosis Factor-alpha; Vasculitis; Young Adult	2012
[Iatrogenic lung diseases]. Klinicheskaia meditsina, 2012, Volume: 90, Issue:4 Topics: Adult; Crohn Disease; Enzyme Inhibitors; Humans; Iatrogenic Disease; Lung Diseases; Male; Methotrexate; Young Adult	2012
Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease. Alimentary pharmacology & therapeutics, 2013, Volume: 37, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Adult; Area Under Curve; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Ontario; Therapeutic Equivalency	2013
Severe deafness associated with Crohn's disease and spondylarthropathy: successful treatment with anti-TNF. Rheumatology (Oxford, England), 2013, Volume: 52, Issue:6 Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Crohn Disease; Deafness; Drug Therapy, Combination; Glucocorticoids; Hearing Loss, Sensorineural; Humans; Male; Methotrexate; Prednisone; Spondylarthropathies; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult	2013
Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:6 Topics: Adolescent; Adult; Crohn Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Retrospective Studies; Treatment Outcome; Young Adult	2013
Inflammatory bowel disease in pregnancy. Gut, 2003, Volume: 52, Issue:2 Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Steroids; Sulfasalazine	2003
[Maintaining a remission]. Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors	2003
[Chronically active Crohn's disease]. Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Chronic Disease; Contraindications; Crohn Disease; Endoscopy; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nutritional Physiological Phenomena; Placebos; Prednisone; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Ultrasonography	2003
[Follow up of Crohn's disease under therapy with hydro-MRI]. Der Radiologe, 2003, Volume: 43, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azathioprine; Crohn Disease; Cyclosporins; Enema; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Sulfonamides; Time Factors	2003
Inducing remission in inflammatory bowel disease. Drug and therapeutics bulletin, 2003, Volume: 41, Issue:4 Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Remission Induction	2003
A lupus-like syndrome associated with infliximab therapy. Inflammatory bowel diseases, 2003, Volume: 9, Issue:3 Topics: Antibodies, Monoclonal; Crohn Disease; Diagnosis, Differential; Female; Humans; Infliximab; Infusions, Intravenous; Injections, Subcutaneous; Lupus Vulgaris; Methotrexate; Middle Aged; Syndrome	2003
Discussion on predictors of response to infliximab in patients with Crohn's disease. Gastroenterology, 2003, Volume: 124, Issue:7 Topics: Antibodies, Monoclonal; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Methotrexate; Time Factors; Tumor Necrosis Factor-alpha	2003
Response of cutaneous Crohn's disease to infliximab and methotrexate. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:5 Topics: Adult; Antibodies, Monoclonal; Crohn Disease; Cutaneous Fistula; Dermatologic Agents; Disease Progression; Drug Therapy, Combination; Female; Humans; Infliximab; Methotrexate; Recurrence; Skin Diseases	2003
Methotrexate-induced esophagitis in a child with Crohn disease. Journal of pediatric gastroenterology and nutrition, 2003, Volume: 37, Issue:4 Topics: Adolescent; Arthritis; Biopsy; Crohn Disease; Esophagitis; Esophagoscopy; Female; Humans; Methotrexate; Mucous Membrane; Triamcinolone	2003
Is there any remaining role for methotrexate for Crohn's disease? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:9 Topics: Azathioprine; Crohn Disease; Enzyme Inhibitors; Female; Humans; Male; Methotrexate	2003
Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine. Alimentary pharmacology & therapeutics, 2004, Feb-01, Volume: 19, Issue:3 Topics: Adult; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Male; Methotrexate; Middle Aged; Prospective Studies	2004
Strictures from Crohn's disease diagnosed by video capsule endoscopy. Journal of clinical gastroenterology, 2004, Volume: 38, Issue:4 Topics: Adult; Antibodies, Monoclonal; Constriction, Pathologic; Crohn Disease; Endoscopy, Gastrointestinal; Female; Gastrointestinal Agents; Humans; Ileitis; Infliximab; Methotrexate; Videotape Recording	2004
[Bone marrow aplasia following dipyrone treatment in a patient with Crohn's disease receiving long-term methotrexate]. Gastroenterologie clinique et biologique, 2004, Volume: 28, Issue:5 Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dipyrone; Female; Humans; Immunosuppressive Agents; Methotrexate; Time Factors	2004
Experience with the use of low-dose methotrexate for inflammatory bowel disease. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:9 Topics: Adolescent; Adult; Aged; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome	2004
Anti-Saccharomyces cerevisiae antibodies and response to infliximab in refractory Crohn's disease. Alimentary pharmacology & therapeutics, 2004, Oct-01, Volume: 20, Issue:7 Topics: Antibodies, Fungal; Antibodies, Monoclonal; Crohn Disease; Drug Resistance, Fungal; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Intestinal Fistula; Methotrexate; Saccharomyces cerevisiae	2004
Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Crohn Disease; Cyclophosphamide; Cytomegalovirus Infections; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Gastritis; Gastrointestinal Hemorrhage; Heart Diseases; Humans; Lymphoma, T-Cell; Male; Methotrexate; Prednisone; Skin Neoplasms; Tumor Necrosis Factor-alpha; Vincristine	2004
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD]. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9 Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intramuscular; Male; Mercaptopurine; Methotrexate; Placebos; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Time Factors	2004
Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease? Inflammatory bowel diseases, 2004, Volume: 10, Issue:5 Topics: Adult; Azathioprine; Colon; Crohn Disease; Female; Gastrointestinal Agents; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Postoperative Care; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome	2004
[Immunosuppressed patient becomes pregnant. Termination of pregnancy unavoidable?]. MMW Fortschritte der Medizin, 2004, Jul-08, Volume: 146, Issue:27-28 Topics: Abortion, Eugenic; Colitis, Ulcerative; Contraindications; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Methotrexate; Pregnancy; Pregnancy Complications; Risk Factors	2004
Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody. Reviews in gastroenterological disorders, 2004,Fall, Volume: 4, Issue:4 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Crohn Disease; Disease Progression; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infliximab; Methotrexate; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	2004
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut, 2005, Volume: 54, Issue:2 Topics: Adult; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Humans; Immunosuppressive Agents; Intestinal Obstruction; Male; Methotrexate; Middle Aged; Retrospective Studies	2005
Crohn's disease over 20 years after diagnosis in a referral population. Gastroenterologie clinique et biologique, 2004, Volume: 28, Issue:12 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; France; Health Status; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Male; Mesalamine; Methotrexate; Middle Aged; Multivariate Analysis; Parenteral Nutrition, Home; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires	2004
Methotrexate for Crohn's disease: experience in a district general hospital. European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:9 Topics: Adult; Aged; Crohn Disease; Diffusion of Innovation; Drug Administration Schedule; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Hospitals, District; Hospitals, General; Humans; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome	2005
Successful treatment with adalimumab in infliximab-resistant Crohn's disease. Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:9 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Prednisolone; Recurrence; Reoperation; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha	2005
[Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?]. Deutsche medizinische Wochenschrift (1946), 2005, Aug-26, Volume: 130, Issue:34-35 Topics: Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Biopsy; Bone and Bones; Bone Density; Crohn Disease; Dose-Response Relationship, Drug; Female; Femur Head Necrosis; Follow-Up Studies; Hip; Humans; Long-Term Care; Methotrexate; Middle Aged; Muscle Weakness; Osteonecrosis; Prednisone; Recurrence	2005
The pharmacogenetics of methotrexate in inflammatory bowel disease. Pharmacogenetics and genomics, 2005, Volume: 15, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Case-Control Studies; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; DNA; Female; gamma-Glutamyl Hydrolase; Genetic Predisposition to Disease; Genotype; Humans; Male; Maximum Tolerated Dose; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein; Transcription Factors; Treatment Outcome	2005
A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2005, Volume: 19, Issue:9 Topics: Adult; Canada; Crohn Disease; Drug Utilization; Gastroenterology; Health Care Surveys; Humans; Immunosuppressive Agents; Methotrexate; Practice Patterns, Physicians'; Surveys and Questionnaires	2005
Methotrexate" "lessons from rheumatology". Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2005, Volume: 19, Issue:9 Topics: Crohn Disease; Drug Administration Routes; Humans; Immunosuppressive Agents; Methotrexate; Rheumatology	2005
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease. Journal of clinical gastroenterology, 2006, Volume: 40, Issue:2 Topics: Adolescent; Azathioprine; Biomarkers; Chi-Square Distribution; Child; Child, Preschool; Crohn Disease; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Predictive Value of Tests; Prospective Studies; Statistics, Nonparametric	2006
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut, 2006, Volume: 55 Suppl 1 Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Clinical Trials as Topic; Crohn Disease; Drug Resistance; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Patient Selection; Purines; Remission Induction; Secondary Prevention	2006
Cutaneous Crohn's disease mimicking Melkersson-Rosenthal syndrome: treatment with methotrexate. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:4 Topics: Adult; Crohn Disease; Dermatologic Agents; Diagnosis, Differential; Face; Female; Granuloma; Humans; Melkersson-Rosenthal Syndrome; Methotrexate	2006
Treatment of vulval Crohn's disease with infliximab. Clinical and experimental dermatology, 2006, Volume: 31, Issue:3 Topics: Abdominal Wall; Adult; Antibodies, Monoclonal; Cesarean Section; Cicatrix; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Prednisolone; Treatment Outcome; Tumor Necrosis Factor-alpha; Vulvar Diseases	2006
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. Alimentary pharmacology & therapeutics, 2006, Jun-01, Volume: 23, Issue:11 Topics: Adult; Biopsy; Crohn Disease; Diagnostic Techniques, Digestive System; Elasticity; Female; Humans; Liver Cirrhosis; Male; Methotrexate; Middle Aged; Prospective Studies	2006
[Infliximab-induced hepatitis in a patient with Crohn's disease]. Gastroenterologia y hepatologia, 2006, Volume: 29, Issue:5 Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mesalamine; Methotrexate; Pancreatitis; Prednisone; Rectovaginal Fistula	2006
Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease. Alimentary pharmacology & therapeutics, 2006, Jul-15, Volume: 24, Issue:2 Topics: Adult; Azathioprine; Crohn Disease; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prospective Studies; Remission Induction; Steroids; Treatment Outcome	2006
The pharmacist's role in teaching methotrexate injection for patients with Crohn's disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Oct-01, Volume: 63, Issue:19 Topics: Crohn Disease; Humans; Injections, Subcutaneous; Methotrexate; Patient Education as Topic; Pharmacists; Professional Role; Safety	2006
Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflammatory bowel diseases, 2006, Volume: 12, Issue:11 Topics: Azathioprine; Child; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Remission Induction; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome	2006
Successful paternity of a healthy child while taking methotrexate for Crohn's disease. The American journal of gastroenterology, 2006, Volume: 101, Issue:12 Topics: Adult; Contraindications; Crohn Disease; Fertilization; Humans; Immunosuppressive Agents; Live Birth; Male; Methotrexate	2006
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. Gut, 2007, Volume: 56, Issue:9 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibody Formation; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome	2007
Angioimmunoblastic T-cell lymphoma mimicking Crohn's disease. Digestive diseases and sciences, 2007, Volume: 52, Issue:10 Topics: Biopsy, Needle; Crohn Disease; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphoma, T-Cell; Methotrexate; Middle Aged; Severity of Illness Index; Tomography, X-Ray Computed	2007
[Filgrastim in refractory Crohn's disease with an intra-abdominal abscess]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:4 Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Cell Differentiation; Combined Modality Therapy; Crohn Disease; Cytokines; Drug Resistance; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infliximab; Macrophages; Male; Methotrexate; Neutrophils; Prednisone; Recombinant Proteins; Tumor Necrosis Factor-alpha	2007
Role of methotrexate in the management of Crohn disease. Journal of pediatric gastroenterology and nutrition, 2007, Volume: 44, Issue:4 Topics: Adolescent; Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate	2007
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Medical Records; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome	2008
[Methotrexate-induced pneumonitis in a woman with Crohn's disease]. Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:34-35 Topics: Acute Disease; Adult; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Pneumonia; Prednisolone; Stomatitis, Aphthous; Tomography, X-Ray Computed; Treatment Outcome	2007
[Abbott proposes in Europe and the U.S.A. the approval of Humira (adalimumab) for therapy of juvenile idiopathic arthritis. Pediatric clinical trial shows very promising results in juvenile rheumatoid arthritis]. Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege, 2007, Volume: 26, Issue:8 Topics: Adalimumab; Adolescent; Adult; Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Crohn Disease; Drug Therapy, Combination; Europe; Humans; Methotrexate; Placebos; Spondylitis, Ankylosing; Time Factors; United States; United States Food and Drug Administration	2007
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Archives of internal medicine, 2007, Sep-10, Volume: 167, Issue:16 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Cecum; Crohn Disease; Digestive System Surgical Procedures; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ileum; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Pilot Projects; Postoperative Period; Prospective Studies; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha	2007
Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. The American journal of gastroenterology, 2007, Volume: 102, Issue:12 Topics: Adolescent; Chi-Square Distribution; Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Retrospective Studies; Statistics, Nonparametric; Treatment Failure; Treatment Outcome	2007
Use of methotrexate in refractory Crohn's disease: the Edinburgh experience. Inflammatory bowel diseases, 2008, Volume: 14, Issue:6 Topics: Adolescent; Adult; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Injections, Intramuscular; Male; Methotrexate; Prednisolone; Remission Induction; Retrospective Studies	2008
Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice. Journal of clinical gastroenterology, 2008, Volume: 42, Issue:4 Topics: Adolescent; Adult; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Risk Factors; Time Factors; Treatment Outcome	2008
The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature. Journal of pediatric endocrinology & metabolism : JPEM, 2007, Volume: 20, Issue:12 Topics: Administration, Oral; Adolescent; Age Determination by Skeleton; Age Factors; Antibodies, Monoclonal; Body Height; C-Reactive Protein; Child; Crohn Disease; Dose-Response Relationship, Drug; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Infliximab; Injections, Subcutaneous; Male; Methotrexate; Physical Examination; Puberty; Recombinant Proteins; Retrospective Studies; Serum Albumin; Time Factors; Treatment Outcome	2007
Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited? Gastroenterologie clinique et biologique, 2008, Volume: 32, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; C-Reactive Protein; Cohort Studies; Crohn Disease; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Treatment Outcome	2008
Methotrexate for Crohn's disease. The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9 Topics: Azathioprine; Crohn Disease; Humans; Mercaptopurine; Methotrexate; Prednisone; Remission Induction	1995
Methotrexate for chronic diseases in adults. The New England journal of medicine, 1995, Feb-02, Volume: 332, Issue:5 Topics: Adult; Arthritis, Rheumatoid; Chronic Disease; Crohn Disease; Drug Monitoring; Humans; Methotrexate	1995
[Crohn's disease: treatment with methotrexate]. Medicina clinica, 1993, Nov-06, Volume: 101, Issue:15 Topics: Adult; Crohn Disease; Female; Humans; Methotrexate	1993
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. The American journal of gastroenterology, 1993, Volume: 88, Issue:1 Topics: Adolescent; Adult; Attitude of Health Personnel; Azathioprine; Child; Colitis; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Gastroenterology; Health Surveys; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Pediatrics; Remission Induction; Retrospective Studies; Societies, Medical; Surveys and Questionnaires	1993
Methotrexate for refractory Crohn's disease: preliminary answers to definitive questions. Mayo Clinic proceedings, 1996, Volume: 71, Issue:1 Topics: Anti-Inflammatory Agents; Crohn Disease; Drug Resistance; Humans; Methotrexate	1996
Methotrexate and ulcerative colitis: wrong drug? Wrong dose? Or wrong disease? Gastroenterology, 1996, Volume: 110, Issue:5 Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Prednisone	1996
Analyzing bivariate repeated measures for discrete and continuous outcome variables. Biometrics, 1996, Volume: 52, Issue:2 Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Biometry; Crohn Disease; Data Interpretation, Statistical; Humans; Linear Models; Methotrexate; Models, Statistical; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Regression Analysis	1996
[Periostosis and Crohn disease: value of methotrexate]. Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:11 Topics: Adrenal Cortex Hormones; Crohn Disease; Drug Resistance; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Male; Methotrexate; Middle Aged; Periostitis	1995
Immunomodulator therapy of inflammatory bowel disease. Acta clinica Belgica, 1997, Volume: 52, Issue:5 Topics: Antimetabolites, Antineoplastic; Azathioprine; Blood Component Removal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate	1997
Methotrexate treatment for Crohn's disease. Inflammatory bowel diseases, 1998, Volume: 4, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Child; Clinical Trials as Topic; Crohn Disease; Humans; Methotrexate; Remission Induction	1998
Sarcoidosis presenting as granulomatous colitis. The American journal of gastroenterology, 1998, Volume: 93, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Colon; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Middle Aged; Sarcoidosis	1998
Methotrexate in refractory Crohn's disease. Inflammatory bowel diseases, 1999, Volume: 5, Issue:1 Topics: Adolescent; Adult; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome	1999
[Fatal bone marrow aplasia after the 1st injection of methotrexate in a woman with Crohn's disease]. Gastroenterologie clinique et biologique, 1999, Volume: 23, Issue:10 Topics: Anemia, Aplastic; Crohn Disease; Female; Folic Acid Antagonists; Humans; Injections, Intramuscular; Methotrexate; Middle Aged	1999
New therapeutic approaches to Crohn's disease. The New England journal of medicine, 2000, Jun-01, Volume: 342, Issue:22 Topics: Crohn Disease; Human Growth Hormone; Humans; Methotrexate; Remission Induction; Secondary Prevention	2000
Long-term treatment of Crohn's disease with methotrexate, or, why's a nice drug like you still a wannabe in the treatment of inflammatory bowel disease? The American journal of gastroenterology, 2000, Volume: 95, Issue:7 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Time Factors	2000
Controlling Crohn's disease. Health news (Waltham, Mass.), 2000, Volume: 6, Issue:7 Topics: Crohn Disease; Human Growth Hormone; Humans; Immunosuppressive Agents; Methotrexate	2000
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. The American journal of gastroenterology, 2000, Volume: 95, Issue:11 Topics: Adult; Biopsy; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Female; Folic Acid Antagonists; Humans; Liver; Male; Methotrexate; Time Factors	2000
Efficacy of parenteral methotrexate in refractory Crohn's disease. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:1 Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Crohn Disease; Female; Humans; Immunosuppressive Agents; Injections; Male; Methotrexate; Middle Aged	2001
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease. Inflammatory bowel diseases, 2000, Volume: 6, Issue:4 Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Treatment Outcome	2000
How effective is extensive nonsurgical treatment of patients with clinically active Crohn's disease of the terminal ileum in preventing surgery? Digestive surgery, 2001, Volume: 18, Issue:1 Topics: Adult; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ileitis; Immunosuppressive Agents; Jejunoileal Bypass; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Reference Values; Retrospective Studies; Secondary Prevention; Sensitivity and Specificity; Severity of Illness Index; Steroids; Treatment Outcome	2001
[A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators]. Gastroenterologie clinique et biologique, 2000, Volume: 24, Issue:12 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Research Design; Treatment Outcome	2000
Methotrexate in Crohn's disease. Gut, 2001, Volume: 48, Issue:6 Topics: Controlled Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Injections, Intramuscular; Liver Function Tests; Methotrexate; Treatment Outcome	2001
Methotrexate: a useful alternative in Crohn's disease? Gut, 2001, Volume: 49, Issue:1 Topics: Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Secondary Prevention; Treatment Outcome	2001
Methotrexate and maintenance of remission in Crohn's disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2001, Volume: 15, Issue:7 Topics: Antimetabolites; Crohn Disease; Humans; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction	2001
Growth failure in the child with inflammatory bowel disease. Seminars in gastrointestinal disease, 2001, Volume: 12, Issue:4 Topics: Adolescent; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Biopsy; Bone Density; Child; Colonoscopy; Crohn Disease; Female; Gastrointestinal Agents; Growth Disorders; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate	2001
Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Annals of internal medicine, 1989, Mar-01, Volume: 110, Issue:5 Topics: Colitis, Ulcerative; Colonoscopy; Crohn Disease; Humans; Methotrexate; Parenteral Nutrition, Total; Prednisone; Sigmoidoscopy	1989
[Treatment of autoimmune diseases]. Schweizerische medizinische Wochenschrift, 1971, Oct-02, Volume: 101, Issue:39 Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Blood Protein Disorders; Child, Preschool; Chloramphenicol; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Drug Synergism; Female; Hepatitis; Humans; Immunosuppressive Agents; Long-Term Care; Lupus Vulgaris; Male; Methotrexate; Middle Aged; Nephrosis, Lipoid; Pemphigus; Polyarteritis Nodosa; Postoperative Complications; Purpura, Thrombocytopenic; Scleroderma, Systemic; Transplantation, Homologous	1971
Immunosuppressive therapy. The American journal of the medical sciences, 1973, Volume: 265, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Antigen-Antibody Reactions; Arthritis, Rheumatoid; Azathioprine; Crohn Disease; Cyclophosphamide; Female; Glomerulonephritis; Glucocorticoids; Hepatitis; Humans; Immunity; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Purpura, Thrombocytopenic	1973